Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
class A beta-lactamase GES-29
Overview
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| blaGES-29 | Card DatabaseReference Gene CatalogReslit | 4 | CEPHALOSPORIN, ceftazidime avibactam | Pseudomonas aeruginosa | Spain | 2024 | KT997885.1 | ALM96712.1 |
| blaGES-34 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | MG748726.1 | AUM56802.1 |
| blaGES-35 | Card DatabaseReference Gene CatalogReslit | 5 | CEPHALOSPORIN, carbapenems +1 | Acinetobacter baumannii | Alexandria, Egypt, Middle East|Europe|Asia|South America|Peru|Egypt|Saudi Arabia|Denmark|Pakistan|Jordan|Iraq|Lebanon|China|Ghana | 2023, 2025 | MH388469.1 | AWN81339.1 |
| blaGES-36 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | LC385763.1 | BBE28626.1 |
| blaGES-37 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | LC385764.1 | BBE28627.1 |
| blaGES-42 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | MN065796.1 | QDC28519.1 |
| blaGES-43 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | MN219691.1 | QDY98368.1 |
| blaGES-46 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | MW295358.1 | QPN97000.1 |
| blaGES-55 | Card DatabaseReference Gene Catalog | 2 | AVIBACTAM, CEPHALOSPORIN | Serratia marcescens | - | - | ON714048.1 | UUF81220.1 |
| blaGES-56 | Card DatabaseReference Gene Catalog | 2 | CEPHALOSPORIN | Acinetobacter baumannii | - | - | OP158701.1 | UUT09019.1 |
| blaGES-57 | Card DatabaseReference Gene Catalog | 2 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | OP716785.1 | UYS49421.1 |
| blaGES-58 | Card DatabaseReference Gene Catalog | 2 | CEPHALOSPORIN | Enterobacter asburiae | - | - | LC763412.1 | BED98385.1 |
| blaGES-59 | Card DatabaseReference Gene Catalog | 2 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | OQ813783.1 | WGG88839.1 |
| blaGES-60 | Card DatabaseReference Gene CatalogReslit | 3 | CEPHALOSPORIN, ceftazidime avibactam | Pseudomonas aeruginosa | Spain | 2024 | PP695362.1 | WZW61385.1 |
| blaGES-61 | Card DatabaseReference Gene Catalog | 2 | CARBAPENEM | Aeromonas caviae | - | - | JAYGON010000276.1 | MEA9429459.1 |
| blaGES-62 | Card DatabaseReference Gene Catalog | 2 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | PQ117759.1 | XFH17877.1 |
| blaGES-65 | Card DatabaseReference Gene Catalog | 2 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | PQ394547.1 | XHO32890.1 |
| blaGES-66 | Card DatabaseReference Gene Catalog | 3 | CARBAPENEM | Klebsiella pneumoniae | - | - | CP173044.1 | XLJ41066.1 |
| blaGES-67 | Reference Gene Catalog | 1 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | PV088249.1 | XPD12781.1 |
| blaGES-68 | Reference Gene Catalog | 1 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | PX238429.1 | YAJ19486.1 |
| blaGES-69 | Reference Gene Catalog | 1 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | PX278758.1 | YAB40485.1 |
| blaGES-70 | Reference Gene Catalog | 1 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | - | PX654923.1 | YCB24323.1 |
| blaGES-25 | Card DatabaseReference Gene Catalog | 3 | CARBAPENEM | Citrobacter freundii | - | 2009 | NG_049128.1 | WP_063860510.1 |
| blaGES-27 | Card DatabaseReference Gene CatalogReslit | 4 | CEPHALOSPORIN, ceftazidime avibactam | Pseudomonas aeruginosa | Spain | 2016, 2024 | NG_049130.1 | WP_063860512.1 |
| blaGES-28 | Card DatabaseReference Gene Catalog | 3 | CARBAPENEM | Pseudomonas aeruginosa | - | 2009 | NG_049131.1 | WP_063860513.1 |
| blaGES-30 | Card DatabaseReference Gene Catalog | 3 | CARBAPENEM | Pseudomonas aeruginosa | - | 2009 | NG_049134.1 | WP_063860516.1 |
| blaGES-31 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Aeromonas caviae | - | 2009 | NG_049135.1 | WP_063860517.1 |
| blaGES-32 | Card DatabaseReference Gene CatalogReslit | 4 | CEPHALOSPORIN, ceftazidime +1 | Pseudomonas aeruginosa | Mexico | 2009, 2018 | NG_051512.1 | WP_069280709.1 |
| blaGES-33 | Card DatabaseReference Gene Catalog | 3 | CARBAPENEM | Pseudomonas aeruginosa | - | 2009 | NG_054709.1 | WP_085562419.1 |
| blaGES-38 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | 2009 | NG_062215.1 | WP_122630826.1 |
| blaGES-39 | Card DatabaseReference Gene CatalogReslit | 4 | CARBAPENEM, meropenem | Pseudomonas aeruginosa | Guangdong, China | 2009, 2023 | NG_062216.1 | WP_122630827.1 |
| blaGES-40 | Card DatabaseReference Gene Catalog | 3 | CARBAPENEM | Pseudomonas aeruginosa | - | 2009 | NG_062356.1 | WP_123002100.1 |
| blaGES-41 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | 2009 | NG_065425.1 | WP_135350920.1 |
| blaGES-44 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | 2009 | NG_070735.1 | WP_188331868.1 |
| blaGES-45 | Card DatabaseReference Gene Catalog | 3 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | 2009 | NG_070736.1 | WP_188331869.1 |
| blaGES-7 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 12 | TICARCILLIN, CEPHALOSPORIN +24 | Escherichia coli +10 | Paris, France, Greece, Czech Republic, Guadeloupe, Europe | 2000, 2010, 2011, 2014, 2022, 2023, 2025 | AY260546.3 | AAP22974.1 |
| blaGES-1 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 45 | ceftazidime, TICARCILLIN +29 | Klebsiella pneumoniae +25 | France|French Guiana, Portugal, Spain, Iran, Brazil, Arabian Peninsula|Saudi Arabia|United Arab Emirates|Kuwait|Oman|Qatar|Bahrain, Middle East|Afghanistan|Iraq|Egypt|Pakistan|Lebanon|Iran|Jordan|Persian Gulf Countries|United Arab Emirates|Kuwait|Qatar|Bahrain|Oman|Saudi Arabia|Turkey, USA|Global, Northern China, Warsaw, Poland|Poland|Canada, Tehran|Qazvin|Iran, Croatia|India, Peru, Germany, India, Europe, Czech Republic, China, South China, Southern Italy, Israel | 2000, 2003, 2009, 2010, 2011, 2012, 2013, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025 | AF156486 | AAF27723.1 |
| blaGES-2 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 13 | imipenem, TICARCILLIN +24 | Pseudomonas aeruginosa +4 | South Africa, USA|Global, Europe, Romania, Brazil, Quebec|Shenzhen Bay | 2001, 2010, 2011, 2015, 2022, 2023, 2024, 2025 | AF326355 | AAK58421.1 |
| blaGES-8 | Card DatabaseReference Gene CatalogResFinder Database | 4 | TICARCILLIN, CEPHALOSPORIN +7 | Pseudomonas aeruginosa | - | 2001 | AF329699.1 | AAK18183.1 |
| blaGES-5 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 63 | TICARCILLIN, AMOXICILLIN +28 | Escherichia coli +27 | Spain, Arabian Peninsula|Saudi Arabia|United Arab Emirates|Kuwait|Oman|Qatar|Bahrain, north-east India, USA|Global, Japan|Nepal|Vietnam, Japan|Taiwan, South Africa, Portugal, US, Pakistan|United States|USA, Indonesia, United Kingdom, Germany, France, Brazil, Europe, Singapore, Saudi Arabia, Czech Republic, Europe|Portugal, Pakistan, South Australia, Korea, various countries|Global, Zagreb, Croatia, Czech Republic|location A|location B|location C, Saudi Arabia|Riyadh|Jeddah|Makkah|Al Jouf|Aseer|Najran|Eastern Region|Western Region|Northern Region|Southern Region, Japan, China, South Africa|Spain|Netherlands|Switzerland|India|China|Germany|Russia|USA|Australia|Other countries, USA|China|India|Thailand|Brazil|Hungary|South Africa|Egypt|Tunisia|Europe|Asia, Australia, Latvia, Asia/South Pacific|Europe|Latin America|Middle East/Africa|North America, Israel, Africa|Americas|Asia|Europe|Oceania, Europe|Italy, Europe|Switzerland, Quebec|Shenzhen Bay | 2004, 2007, 2009, 2010, 2011, 2013, 2014, 2015, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025 | AY494717.1 | AAR97270.1 |
| blaGES-6 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 14 | TICARCILLIN, AMOXICILLIN +21 | Klebsiella pneumoniae +8 | Japan|Nepal|Vietnam, Japan|Taiwan, Portugal, Korea, Japan, Asia/South Pacific|Europe|Latin America|Middle East/Africa|North America | 2004, 2010, 2017, 2018, 2019, 2020, 2022, 2023, 2024 | AY494718.1 | AAR97271.1 |
| blaGES-3 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 5 | ceftazidime, TICARCILLIN +8 | Klebsiella pneumoniae +1 | Japan | 2004 | AB113580 | BAD06399.1 |
| blaGES-4 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 6 | cefoxitin, imipenem +11 | Klebsiella pneumoniae +2 | Japan | 2004, 2022 | AB116260|AB116723 | BAD08689.1 |
| blaGES-9 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 9 | aztreonam, AZTREONAM +14 | Pseudomonas aeruginosa +3 | France, India, United States | 2005, 2013, 2021, 2023 | AY920928 | AAY43207.1 |
| blaGES | Reslit | 58 | ceftazidime, cefepime +18 | Pseudomonas aeruginosa +34 | Rio de Janeiro|Brazil, Germany, Iran, Libya, USA|Global, China, France, Argentina|India|Mexico|Brazil|France|Spain|Germany|China|Philippines|Colombia|Croatia, Shenzhen, southern China, Peru, Morocco, Philippines, South Korea, Spain, Brazil, Thailand, Brazil|Czech Republic|Germany|India|Japan|Kenya|Kuwait|Nigeria|Philippines|South Korea|Thailand|United States, Egypt, South Africa, Eastern Cape Province, Republic of South Africa|South Africa, Burkina Faso, Southern Thailand|Thailand, Asia|Pacific, Finland, Northern China, various countries|Global, China|global, Faisalabad, Pakistan, United States|Canada|Europe, Ivory Coast|Ghana, Europe|Ukraine, Mexico, Kenya, Argentina, Iraq, Russia, Central Adriatic Sea, Europe|Austria | 2006, 2013, 2014, 2015, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025 | PDB:3E2K|PDB:3E2L|PDB:3RXW|PDB:3RXX|PDB:3NI9|PDB:3NIA|PDB:4QU3|PDB:4GNU|PDB:4H8R|PDB:3V3S|PDB:4EQI|PDB:4EUZ|PDB:4EV4|PDB:1BUE|PDB:1BUL|PDB:1DY6|PDB:3W4Q | - |
| blaGES-11 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 28 | aztreonam, carbapenems +19 | Acinetobacter baumannii +7 | Belgium, Kuwait, Arabian Peninsula|Saudi Arabia|United Arab Emirates|Kuwait|Oman|Qatar|Bahrain, United States, Brazil, Pakistan, Afghanistan, Europe, Ethiopia, various countries|Global, Europe|Asia|North America|Western and South-Eastern Asia, Egypt, Saudi Arabia|Riyadh|Jeddah|Makkah|Al Jouf|Aseer|Najran|Eastern Region|Western Region|Northern Region|Southern Region, Alexandria, Egypt, Asia|North America|Europe|Australia, Canada, Middle East|Europe|Asia|South America|Peru|Egypt|Saudi Arabia|Denmark|Pakistan|Jordan|Iraq|Lebanon|China|Ghana | 2009, 2010, 2012, 2013, 2014, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025 | FJ854362 | ACS44714.1 |
| blaGES-10 | Card DatabaseReference Gene CatalogResFinder Database | 4 | TICARCILLIN, CEPHALOSPORIN +7 | uncultured bacterium | - | 2009 | FJ820124.1 | ACS73598.1 |
| blaGES-14 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 13 | TICARCILLIN, AMOXICILLIN +18 | Acinetobacter baumannii +3 | Belgium, France, Kuwait, various countries|Global | 2009, 2010, 2011, 2012, 2013, 2014, 2021, 2022, 2023 | GU207844.1 | ADC91899.1 |
| blaGES-16 | Card DatabaseReference Gene CatalogResFinder Database | 4 | TICARCILLIN, AMOXICILLIN +7 | Serratia marcescens | - | 2009 | HM173356.1 | ADJ94120.1 |
| blaGES-17 | Card DatabaseReference Gene CatalogResFinder Database | 4 | TICARCILLIN, CEPHALOSPORIN +7 | Escherichia coli | - | 2009 | HQ874631.1 | ADZ48685.1 |
| blaGES-18 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 5 | TICARCILLIN, AMOXICILLIN +9 | Pseudomonas aeruginosa +1 | Belgium | 2009, 2013 | JQ028729.1 | AEX59144.1 |
| blaGES-19 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 8 | TICARCILLIN, CEPHALOSPORIN +15 | Escherichia coli +2 | Mexico, United States, Colombia|Chile|Argentina|Mexico|Brazil | 2009, 2012, 2019, 2022, 2023 | JN596280.1 | AEZ05107.1 |
| blaGES-20 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 11 | TICARCILLIN, AMOXICILLIN +16 | Escherichia coli +12 | Mexico, Middle East|Afghanistan|Iraq|Egypt|Pakistan|Lebanon|Iran|Jordan|Persian Gulf Countries|United Arab Emirates|Kuwait|Qatar|Bahrain|Oman|Saudi Arabia|Turkey, United States|Mexico, Colombia|Chile|Argentina|Mexico|Brazil, Asia/South Pacific|Europe|Latin America|Middle East/Africa|North America, Europe, Bolivia | 2009, 2012, 2015, 2022, 2023, 2024, 2025 | JN596280.1 | AEZ05108.1 |
| blaGES-21 | Card DatabaseReference Gene CatalogResFinder Database | 4 | TICARCILLIN, AMOXICILLIN +7 | uncultured bacterium | - | 2009 | JQ772478.1 | AFK80745.1 |
| blaGES-23 | Card DatabaseReference Gene CatalogResFinder Database | 4 | TICARCILLIN, CEPHALOSPORIN +7 | Pseudomonas aeruginosa | - | 2009 | KF179354.1 | AGT20529.1 |
| blaGES-24 | Card DatabaseReference Gene CatalogReslit | 6 | CARBAPENEM, carbapenems | Acinetobacter sp. +7 | South Korea, Japan|Taiwan, Japan, South Africa|Spain|Netherlands|Switzerland|India|China|Germany|Russia|USA|Australia|Other countries | 2009, 2016, 2018, 2023 | AB901141.1 | BAP75641.1 |
| blaGES-26 | Card DatabaseReference Gene CatalogReslit | 4 | CEPHALOSPORIN, aztreonam +4 | Pseudomonas aeruginosa +1 | United States | 2009, 2019, 2022 | KP096411.1 | AJP67510.1 |
| blaGES-47 | Card DatabaseReference Gene Catalog | 2 | CARBAPENEM | Klebsiella michiganensis | - | 2009 | LC612389.1 | BCT36862.1 |
| blaGES-48 | Card DatabaseReference Gene Catalog | 2 | CARBAPENEM | Aeromonas caviae | - | 2009 | LC612390.1 | BCT36863.1 |
| blaGES-49 | Card DatabaseReference Gene Catalog | 2 | CARBAPENEM | Aeromonas veronii bv. veronii | - | 2009 | LC637995.1 | BCY26593.1 |
| blaGES-50 | Card DatabaseReference Gene Catalog | 2 | CARBAPENEM | Klebsiella michiganensis | - | 2009 | LC654878.1 | BDB58072.1 |
| blaGES-51 | Card DatabaseReference Gene CatalogReslit | 3 | CARBAPENEM, carbapenems | Citrobacter portucalensis +1 | Europe|Czech Republic | 2009, 2024 | LC654879.1 | BDB58073.1 |
| blaGES-52 | Card DatabaseReference Gene Catalog | 2 | CEPHALOSPORIN | Pseudomonas aeruginosa | - | 2009 | ON166564.1 | UOM32505.1 |
| blaGES-53 | Card DatabaseReference Gene Catalog | 2 | CARBAPENEM | Enterobacter cloacae | - | 2009 | ON418962.1 | UQM94989.1 |
| blaGES-54 | Card DatabaseReference Gene Catalog | 2 | CARBAPENEM | Enterobacter kobei | - | 2009 | LC709174.1 | BDI54505.1 |
| blaGES-13 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 7 | cephalosporins, aztreonam +19 | Pseudomonas aeruginosa +1 | Greece, Warsaw, Poland|Poland|Canada | 2010, 2017 | GU169702 | ACZ54536.1 |
| blaGES-12 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 9 | ceftazidime, TICARCILLIN +13 | Acinetobacter baumannii +1 | Belgium, various countries|Global, Middle East|Europe|Asia|South America|Peru|Egypt|Saudi Arabia|Denmark|Pakistan|Jordan|Iraq|Lebanon|China|Ghana | 2010, 2012, 2021, 2022, 2025 | HM622144|HM622145|GU207844 | CBG22732.1 |
| blaGES-22 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 8 | cefoxitin, ceftriaxone +15 | Acinetobacter baumannii +1 | Europe|Mediterranean countries, various countries|Global, Middle East|Europe|Asia|South America|Peru|Egypt|Saudi Arabia|Denmark|Pakistan|Jordan|Iraq|Lebanon|China|Ghana | 2014, 2016, 2022, 2025 | JX023441.1 | AFU25739.1 |
| bla_GES | Reslit | 5 | carbapenems, imipenem +6 | Acinetobacter baumannii +2 | Europe|Brazil|China|Switzerland|Iran|Puerto Rico|United States, South Africa, Iran, Mexico | 2016, 2024, 2025 | - | - |
| blaGES-15 | Card DatabaseReference Gene CatalogResFinder DatabaseReslit | 6 | cephalosporins, carbapenems +11 | Pseudomonas aeruginosa | Warsaw, Poland|Poland|Canada, Spain | 2017, 2021 | GU208678|EF552405|EU358785 | ACZ98826.1 |
| GES | Reslit | 2 | carbapenems, cephalosporins | Escherichia coli +1 | Tanzania|Thailand|human|swine, Iran | 2019, 2023 | - | - |
| bla(GES-2) | Reslit | 1 | ceftriaxone, cefotaxime | Pseudomonas aeruginosa +1 | Iran | 2020 | - | - |
| blaGES-5B | Reslit | 1 | carbapenems | Escherichia coli | Germany | 2020 | MT955355 | - |
| bla(GES) | Reslit | 3 | carbapenems, aztreonam +5 | Aeromonas spp. +2 | Brazil, Iran, Mexico City | 2022, 2023 | CP068232|CP068233|CP068231|JAEMTZ000000000|JAEMUA000000000|CP066813|CP066814|CP066859|CP066860|CP067433|CP067435|CP067436.1 | - |
| bla(GES-5) | Reslit | 1 | cephalosporins, penicillin | Pseudomonas aeruginosa | Europe|Switzerland | 2025 | PRJEB82838 | - |
| blaGES-like | Reslit | 1 | cephalosporins | Escherichia coli +1 | Brazil | 2025 | - | - |
Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.
The study identified GES-1, a novel class A extended-spectrum beta-lactamase, which confers resistance to ceftazidime. It was cloned and expressed in E. coli, demonstrating its role in beta-lactam resistance.
Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.
Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.
Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.
IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.
IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.
IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.
GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.
The study identifies GES-2, a class A beta-lactamase from Pseudomonas aeruginosa, which exhibits increased hydrolysis of imipenem compared to GES-1.
GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.
GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.
GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.
GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.
An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1.
An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1.
An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1.
An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1.
Molecular characterization of a new class 3 integron in Klebsiella pneumoniae.
The study identifies a new class 3 integron in Klebsiella pneumoniae FFUL 22K carrying the blaGES-1 gene cassette, which confers resistance to extended-spectrum cephalosporins.
Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria.
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
The study identifies a novel class A beta-lactamase, GES-3, which confers resistance to ceftazidime in ceftazidime-resistant Klebsiella pneumoniae strains isolated from a neonatal intensive care unit in Japan.
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop.
The study identifies GES-4, a class A beta-lactamase with a G170S substitution in the omega-loop, which confers resistance to cephamycins and carbapenems and exhibits inhibitor resistance.
Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop.
Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop.
Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop.
Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A beta-lactamase, GES-4, possessing a single G170S substitution in the omega-loop.
Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.
The study identifies a novel GES-type extended-spectrum beta-lactamase, GES-9, which exhibits increased activity towards aztreonam in Pseudomonas aeruginosa. The gene is located in a class 1 integron and shows resistance to several beta-lactam antibiotics.
Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.
Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.
Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.
Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.
Emergence of blaGES-5 in clinical colistin-only-sensitive (COS) Pseudomonas aeruginosa strain in Brazil.
BlasGES carrying Pseudomonas aeruginosa isolates from a public hospital in Rio de Janeiro, Brazil.
The study identified the blaGES gene in Pseudomonas aeruginosa isolates from a public hospital in Rio de Janeiro, Brazil, which confers resistance to multiple beta-lactam antibiotics including ceftazidime, cefepime, imipenem, meropenem, piperacillin-tazobactam, and ticarcillin-clavulanic acid.
Integron mobilization unit as a source of mobility of antibiotic resistance genes.
The study identifies the blaGES-5 gene, a carbapenemase, located on a novel genetic structure called the integron mobilization unit (IMU), which facilitates the mobilization of antibiotic resistance genes.
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
The study identifies GES-11, a novel integron-associated GES variant in Acinetobacter baumannii, which confers resistance to beta-lactams, including aztreonam, and reduces susceptibility to carbapenems.
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
Evidence for dynamic exchange of qac gene cassettes between class 1 integrons and other integrons in freshwater biofilms.
Evidence for dynamic exchange of qac gene cassettes between class 1 integrons and other integrons in freshwater biofilms.
Evidence for dynamic exchange of qac gene cassettes between class 1 integrons and other integrons in freshwater biofilms.
Evidence for dynamic exchange of qac gene cassettes between class 1 integrons and other integrons in freshwater biofilms.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
The study identifies the first occurrence of GES-1 and GES-5 extended-spectrum beta-lactamases in Spain, which are encoded in a single integron in colistin-only-sensitive Pseudomonas aeruginosa isolates.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
The study identifies the first occurrence of GES-1 and GES-5 extended-spectrum beta-lactamases in Spain, which are encoded in a single integron in colistin-only-sensitive Pseudomonas aeruginosa isolates.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain.
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
The study identifies GES-13, a novel beta-lactamase variant in Pseudomonas aeruginosa with Lys-104 and Asn-170, which effectively hydrolyzes broad-spectrum cephalosporins and aztreonam.
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases.
The study characterized the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases, showing that these mutations influence the hydrolytic activity and substrate specificity of the enzymes, particularly against β-lactam antibiotics.
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases.
The study characterized the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases, showing that these mutations influence the hydrolytic activity and substrate specificity of the enzymes, particularly against β-lactam antibiotics.
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases.
The study characterized the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases, showing that these mutations influence the hydrolytic activity and substrate specificity of the enzymes, particularly against β-lactam antibiotics.
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases.
The study characterized the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases, showing that these mutations influence the hydrolytic activity and substrate specificity of the enzymes, particularly against β-lactam antibiotics.
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases.
The study characterized the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases, showing that these mutations influence the hydrolytic activity and substrate specificity of the enzymes, particularly against β-lactam antibiotics.
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases.
The study characterized the role of naturally occurring mutations at Ambler positions 104 and 170 in GES beta-lactamases, showing that these mutations influence the hydrolytic activity and substrate specificity of the enzymes, particularly against β-lactam antibiotics.
GES Extended-Spectrum beta-lactamases in Acinetobacter baumannii Isolates in Belgium
The study identifies three novel GES variants (GES-11, GES-12, and GES-14) in multidrug-resistant Acinetobacter baumannii isolates from Belgium, highlighting the emergence of carbapenem resistance in this pathogen.
GES Extended-Spectrum beta-lactamases in Acinetobacter baumannii Isolates in Belgium
The study identifies three novel GES variants (GES-11, GES-12, and GES-14) in multidrug-resistant Acinetobacter baumannii isolates from Belgium, highlighting the emergence of carbapenem resistance in this pathogen.
GES Extended-Spectrum beta-lactamases in Acinetobacter baumannii Isolates in Belgium
The study identifies three novel GES variants (GES-11, GES-12, and GES-14) in multidrug-resistant Acinetobacter baumannii isolates from Belgium, highlighting the emergence of carbapenem resistance in this pathogen.
GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium.
GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium.
GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium.
GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium.
Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii.
The study identifies GES-14, a novel carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii, which hydrolyzes all beta-lactams including carbapenems, cephamycins, and monobactams.
Diversity of clavulanic acid-inhibited extended-spectrum beta-lactamases in Aeromonas spp. from the Seine River, Paris, France.
The study identified various clavulanic acid-inhibited extended-spectrum beta-lactamases (ESBLs) in Aeromonas spp. from the Seine River, including blaVEB-1a, blaSHV-12, blaPER-1, blaPER-6, blaTLA-2, and blaGES-7, highlighting the diversity of ESBLs in aquatic environments.
Diversity of clavulanic acid-inhibited extended-spectrum β-lactamases in Aeromonas spp. from the Seine River, Paris, France.
Importance of position 170 in the inhibition of GES-type beta-lactamases by clavulanic acid.
The study highlights the importance of position 170 in GES-type beta-lactamases, showing that the presence of asparagine at this position increases susceptibility to clavulanic acid, while glycine or serine reduces it. GES-2, with asparagine at position 170, exhibits higher affinity for clavulanic acid and greater susceptibility to inhibition compared to GES-1 and GES-5.
Importance of position 170 in the inhibition of GES-type beta-lactamases by clavulanic acid.
The study highlights the importance of position 170 in GES-type beta-lactamases, showing that the presence of asparagine at this position increases susceptibility to clavulanic acid, while glycine or serine reduces it. GES-2, with asparagine at position 170, exhibits higher affinity for clavulanic acid and greater susceptibility to inhibition compared to GES-1 and GES-5.
Importance of position 170 in the inhibition of GES-type beta-lactamases by clavulanic acid.
The study highlights the importance of position 170 in GES-type beta-lactamases, showing that the presence of asparagine at this position increases susceptibility to clavulanic acid, while glycine or serine reduces it. GES-2, with asparagine at position 170, exhibits higher affinity for clavulanic acid and greater susceptibility to inhibition compared to GES-1 and GES-5.
Novel gene cassettes and integrons in antibiotic-resistant bacteria isolated from urban wastewaters.
Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals.
The study identified blaSPM-1, blaGES-1, blaOXA-51, and blaOXA-23 genes in Acinetobacter baumannii isolates from Tehran hospitals, highlighting the emergence of carbapenem resistance due to these beta-lactamase genes.
A plasmid-encoded class 1 integron contains GES-type extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Mexico.
The study identifies two new GES-type extended-spectrum beta-lactamase alleles, GES-19 and GES-20, in Enterobacteriaceae clinical isolates in Mexico, which confer resistance to various beta-lactam antibiotics.
A plasmid-encoded class 1 integron contains GES-type extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Mexico.
The study identifies two new GES-type extended-spectrum beta-lactamase alleles, GES-19 and GES-20, in Enterobacteriaceae clinical isolates in Mexico, which confer resistance to various beta-lactam antibiotics.
A plasmid-encoded class 1 integron contains GES-type extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Mexico.
A plasmid-encoded class 1 integron contains GES-type extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Mexico.
Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 beta-lactamases.
The study characterizes the extended-spectrum beta-lactamases GES-11, GES-12, and GES-14, highlighting their increased hydrolytic activity against various β-lactam antibiotics, including aztreonam, ceftazidime, and cefotaxime, as well as their resistance to certain beta-lactamase inhibitors.
Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 beta-lactamases.
The study characterizes the extended-spectrum beta-lactamases GES-11, GES-12, and GES-14, highlighting their increased hydrolytic activity against various β-lactam antibiotics, including aztreonam, ceftazidime, and cefotaxime, as well as their resistance to certain beta-lactamase inhibitors.
Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 beta-lactamases.
The study characterizes the extended-spectrum beta-lactamases GES-11, GES-12, and GES-14, highlighting their increased hydrolytic activity against various β-lactam antibiotics, including aztreonam, ceftazidime, and cefotaxime, as well as their resistance to certain beta-lactamase inhibitors.
Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait.
The study identified the wide dissemination of GES-type carbapenemases, particularly blaGES-11 and blaGES-14, in Acinetobacter baumannii isolates in Kuwait. It also found that blaOXA-23 was frequently co-harbored with blaGES-11.
Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait.
The study identified the wide dissemination of GES-type carbapenemases, particularly blaGES-11 and blaGES-14, in Acinetobacter baumannii isolates in Kuwait. It also found that blaOXA-23 was frequently co-harbored with blaGES-11.
GES-18, a new carbapenem-hydrolyzing GES-Type beta-lactamase from Pseudomonas aeruginosa that contains Ile80 and Ser170 residues.
The study identifies GES-18, a novel carbapenem-hydrolyzing GES-type beta-lactamase from Pseudomonas aeruginosa, which differs from GES-5 by a single amino acid substitution (Val80Ile) and from GES-1 by two substitutions (Val80Ile and Gly170Ser).
Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.
The study identified blaVIM-2 and blaGES-9 genes in Pseudomonas aeruginosa isolates, which confer resistance to imipenem.
A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection.
The study identified bla CTX-M-2 and bla GES-1 as the main resistance mechanisms in carbapenem-resistant Klebsiella pneumoniae isolates, along with alterations in ompK35 and ompK36 genes contributing to reduced carbapenem susceptibility.
beta-lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.
The study identifies various beta-lactamase genes, including CTX-M-15, CTX-M-14, CTX-M-9, SHV-12, SHV-5, TEM-1, VEB-1, GES-1, GES-5, GES-11, PER-1, OXA-48, NDM-1, VIM-2, OXA-23, OXA-40, OXA-58, and OXA-181, which confer resistance to β-lactam antibiotics in Gram-negative pathogens from the Arabian Peninsula.
beta-lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.
The study identifies various beta-lactamase genes, including CTX-M-15, CTX-M-14, CTX-M-9, SHV-12, SHV-5, TEM-1, VEB-1, GES-1, GES-5, GES-11, PER-1, OXA-48, NDM-1, VIM-2, OXA-23, OXA-40, OXA-58, and OXA-181, which confer resistance to β-lactam antibiotics in Gram-negative pathogens from the Arabian Peninsula.
beta-lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.
The study identifies various beta-lactamase genes, including CTX-M-15, CTX-M-14, CTX-M-9, SHV-12, SHV-5, TEM-1, VEB-1, GES-1, GES-5, GES-11, PER-1, OXA-48, NDM-1, VIM-2, OXA-23, OXA-40, OXA-58, and OXA-181, which confer resistance to β-lactam antibiotics in Gram-negative pathogens from the Arabian Peninsula.
DNA microarray for genotyping antibiotic resistance determinants in Acinetobacter baumannii clinical isolates.
The study developed a DNA microarray for genotyping antibiotic resistance determinants in Acinetobacter baumannii clinical isolates, identifying numerous resistance genes and mutations associated with carbapenem, aminoglycoside, fluoroquinolone, and other antibiotic resistances.
Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam–β-lactamase inhibitor combinations.
Substitutions in the Mycobacterium tuberculosis β-lactamase BlaC, particularly R220A, R220S, A244R, S130G, T237A, and T237S, were found to reduce the effectiveness of clavulanate, although the wild-type BlaC remains susceptible to ampicillin-clavulanate.
Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities.
The study identified multiple antimicrobial resistance genes in Acinetobacter baumannii isolates from military treatment facilities, including bla OXA-51-like, bla OXA-23, bla GES-11, aac(6')-Ib, aacC1, aadB, aphA6, and others, highlighting the complex resistome of these isolates.
Modified CLSI extended-spectrum beta-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various beta-lactamases.
The study evaluated a modified CLSI ESBL confirmatory test for the phenotypic detection of extended-spectrum beta-lactamases (ESBLs) among Enterobacteriaceae producing various beta-lactamases, including KPC, VIM, NDM, and OXA-48. The modified test significantly improved the sensitivity and specificity of ESBL detection compared to the standard CLSI test.
CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp.
The study introduces the CarbAcineto NP test, a modified version of the Carba NP test, for the rapid and accurate detection of carbapenemase-producing Acinetobacter spp. The test successfully identifies various carbapenemases including OXA-23, OXA-24/OXA-40, OXA-58, OXA-143, GES-11, GES-14, NDM-1, NDM-2, IMP-1, IMP-4, VIM-4, and SIM-1.
CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp.
The study introduces the CarbAcineto NP test, a modified version of the Carba NP test, for the rapid and accurate detection of carbapenemase-producing Acinetobacter spp. The test successfully identifies various carbapenemases including OXA-23, OXA-24/OXA-40, OXA-58, OXA-143, GES-11, GES-14, NDM-1, NDM-2, IMP-1, IMP-4, VIM-4, and SIM-1.
Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel beta-lactamases, GES-22 and VIM-35.
The study identified two novel beta-lactamases, GES-22 and VIM-35, which confer resistance to various β-lactam antibiotics. GES-22 showed an extended-spectrum beta-lactamase profile, while VIM-35 exhibited a similar susceptibility profile to VIM-1.
Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35.
Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35.
Evaluation of clonality and carbapenem resistance mechanisms among Acinetobacter baumannii-Acinetobacter calcoaceticus complex and Enterobacteriaceae isolates collected in European and Mediterranean countries and detection of two novel β-lactamases, GES-22 and VIM-35.
Kinetic and structural requirements for carbapenemase activity in GES-type beta-lactamases.
The study characterizes the GES-type beta-lactamases (GES-1, GES-2, and GES-5) and their ability to hydrolyze carbapenems, highlighting the role of specific amino acid substitutions in enhancing carbapenem resistance.
Kinetic and structural requirements for carbapenemase activity in GES-type beta-lactamases.
The study characterizes the GES-type beta-lactamases (GES-1, GES-2, and GES-5) and their ability to hydrolyze carbapenems, highlighting the role of specific amino acid substitutions in enhancing carbapenem resistance.
Kinetic and structural requirements for carbapenemase activity in GES-type beta-lactamases.
The study characterizes the GES-type beta-lactamases (GES-1, GES-2, and GES-5) and their ability to hydrolyze carbapenems, highlighting the role of specific amino acid substitutions in enhancing carbapenem resistance.
A report on the presence of GES-5 extended spectrum beta-lactamase producing Pseudomonas aeruginosa associated with urinary tract infection from north-east India.
The study reports the presence of blaGES-5 encoding an extended-spectrum beta-lactamase in Pseudomonas aeruginosa isolates from urinary tract infections in northeast India, highlighting the need for further investigation into the epidemiology and transmission dynamics of this resistance determinant.
In vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity.
The study identified mutations in the GES-1 β-lactamase that enhance resistance to multiple β-lactam antibiotics, including cefotaxime, ceftazidime, aztreonam, imipenem, and cefoxitin.
Characterization of Plasmid-Mediated AmpC and Carbapenemases among Iranian Nosocomial Isolates of Klebsiella pneumoniae Using Phenotyping and Genotyping Methods.
The study identified plasmid-mediated AmpC beta-lactamases (blaMOX, blaCIT) and carbapenemases (blaVIM, blaGES) in clinical isolates of Klebsiella pneumoniae in Iran, highlighting the high prevalence of these resistance mechanisms.
Modification of the susceptibility of gram-negative rods producing ESβLS to β-lactams by the efflux phenomenon.
The study identified the blaGES-1 gene as a determinant of resistance to cefepime and ceftazidime in Pseudomonas aeruginosa, and showed that efflux pump inhibitors like PAβN could restore susceptibility.
New Delhi metallo-β-lactamase and OXA-48 carbapenemases in Gram-negative bacilli isolates in Libya.
The study identifies the presence of bla NDM, bla OXA-48, bla CTX-M, and bla GES genes in various Gram-negative bacilli isolates in Libya, highlighting the emergence of multidrug-resistant organisms carrying carbapenemase genes.
Molecular Characteristics of Class A beta-lactamases
The paper characterizes various class A beta-lactamases, including TEM-1, GIL-1, OXY, CTX-M, SFO-1, CARBA, GES, PER-1, and VEB-1, highlighting their roles in conferring resistance to β-lactam antibiotics such as penicillins, cephalosporins, and carbapenems.
Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.
Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.
Mutational and acquired carbapenem resistance mechanisms in multidrug resistant Pseudomonas aeruginosa clinical isolates from Recife, Brazil.
The study identifies several AMR genes including blaGES-1, blaKPC-2, blaSPM-1, aac(6')-Ib, ant(2')-Ia, aph(3')-VIa, rmtD, catB3, arr-4, qacED1, sul1, and intI1, as well as mutations in the oprD gene contributing to carbapenem resistance in multidrug-resistant P. aeruginosa isolates from Recife, Brazil.
Dissemination of carbapenemases producing Gram negative bacteria in the Middle East.
The study reviews the dissemination of carbapenemase-producing Gram-negative bacteria in the Middle East, highlighting the prevalence of KPC, VIM, IMP, NDM, and OXA-48 enzymes in various bacterial species such as Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa.
Dissemination of carbapenemases producing Gram negative bacteria in the Middle East.
The study reviews the dissemination of carbapenemase-producing Gram-negative bacteria in the Middle East, highlighting the prevalence of KPC, VIM, IMP, NDM, and OXA-48 enzymes in various bacterial species such as Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa.
Class A Carbapenemases: Mechanisms of Action and Resistance
The paper characterizes various class A carbapenemases, including KPC, GES, SME, NmcA, FRI-1, BIC-1, SFC-1, and PenA, highlighting their roles in conferring resistance to carbapenems and other β-lactam antibiotics.
Class A Carbapenemases: Mechanisms of Action and Resistance
The paper characterizes various class A carbapenemases, including KPC, GES, SME, NmcA, FRI-1, BIC-1, SFC-1, and PenA, highlighting their roles in conferring resistance to carbapenems and other β-lactam antibiotics.
Class A Carbapenemases: Mechanisms of Action and Resistance
The paper characterizes various class A carbapenemases, including KPC, GES, SME, NmcA, FRI-1, BIC-1, SFC-1, and PenA, highlighting their roles in conferring resistance to carbapenems and other β-lactam antibiotics.
Class A Carbapenemases: Mechanisms of Action and Resistance
The paper characterizes various class A carbapenemases, including KPC, GES, SME, NmcA, FRI-1, BIC-1, SFC-1, and PenA, highlighting their roles in conferring resistance to carbapenems and other β-lactam antibiotics.
Kinetic characterization of GES-22 beta-lactamase harboring the M169L clinical mutation.
Prevalence and Fate of Carbapenemase Genes in a Wastewater Treatment Plant in Northern China.
The study identified the prevalence of bla KPC-2, bla GES-1, and bla IMP-1 carbapenemase genes in a wastewater treatment plant, highlighting their persistence through various treatment stages and potential environmental dissemination.
Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.
The study identifies blaIMP-6, blaGES-24, and blaIMP-10 genes on novel genomic islands PAGI-15 and PAGI-16 in Pseudomonas aeruginosa ST235 isolates in South Korea, highlighting the clonal dissemination of these carbapenemase genes.
Insights on the Horizontal Gene Transfer of Carbapenemase Determinants in the Opportunistic Pathogen Acinetobacter baumannii.
The paper discusses the horizontal gene transfer of carbapenemase determinants in Acinetobacter baumannii, focusing on various carbapenemase genes such as bla OXA-23, bla OXA-40, bla OXA-58, bla OXA-143, and bla OXA-235, highlighting their roles in carbapenem resistance and the mechanisms of their dissemination.
Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa.
The study identified bla_NDM, bla_OXA-48, bla_VIM, bla_IMP, bla_GES, and bla_KPC as the most prevalent carbapenemase genes in Enterobacteriaceae isolates in South Africa, with bla_NDM being the most common.
Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods.
The study identified three novel ESBL genes, blaGES-15, blaOXA-141, and blaOXA-142, along with several known ESBL genes in Pseudomonas aeruginosa isolates from Warsaw, Poland.
Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods.
The study identified three novel ESBL genes, blaGES-15, blaOXA-141, and blaOXA-142, along with several known ESBL genes in Pseudomonas aeruginosa isolates from Warsaw, Poland.
Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods.
The study identified three novel ESBL genes, blaGES-15, blaOXA-141, and blaOXA-142, along with several known ESBL genes in Pseudomonas aeruginosa isolates from Warsaw, Poland.
Distribution of the bla OXA , bla VEB-1 , and bla GES-1 genes and resistance patterns of ESBL-producing Pseudomonas aeruginosa isolated from hospitals in Tehran and Qazvin, Iran.
The study identified blaOXA-1, blaOXA-4, blaGES-1, and blaVEB-1 genes as prevalent in ESBL-producing Pseudomonas aeruginosa isolates from hospitals in Tehran and Qazvin, Iran, contributing to resistance against various beta-lactam antibiotics.
Molecular detection of beta-lactamase and integron genes in clinical strains of Klebsiella pneumoniae by multiplex polymerase chain reaction.
The study identified the presence of various beta-lactamase genes (blaTEM, blaCTX-M, blaSHV, blaPER, blaGES, blaVIM, blaIMP, blaOXA, blaKPC) and integron genes (intI, intII, intIII) in clinical strains of Klebsiella pneumoniae, highlighting the prevalence of multidrug resistance.
A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species.
The study introduces a modified carbapenem inactivation method, CIMTris, which shows higher sensitivity than the mCIM for detecting carbapenemase production in Acinetobacter and Pseudomonas species. Several carbapenemase genes, including blaIMP-10, blaIMP-14, blaIMP-15, blaIMP-26, blaIMP-34, blaIMP-43, blaIMP-44, blaIMP-51, blaNDM-1, blaVIM-1, blaVIM-2, blaGES-5, blaGES-6, blaOXA-23, blaOXA-58, blaOXA-72, blaOXA-69, blaOXA-82, blaOXA-98, and blaOXA-51-like, were identified and validated in this study.
A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species.
The study introduces a modified carbapenem inactivation method, CIMTris, which shows higher sensitivity than the mCIM for detecting carbapenemase production in Acinetobacter and Pseudomonas species. Several carbapenemase genes, including blaIMP-10, blaIMP-14, blaIMP-15, blaIMP-26, blaIMP-34, blaIMP-43, blaIMP-44, blaIMP-51, blaNDM-1, blaVIM-1, blaVIM-2, blaGES-5, blaGES-6, blaOXA-23, blaOXA-58, blaOXA-72, blaOXA-69, blaOXA-82, blaOXA-98, and blaOXA-51-like, were identified and validated in this study.
Detection of multidrug-resistant Pseudomonas aeruginosa harboring bla GES-1 and bla GES-11 in Recife, Brazil.
The study detected multidrug-resistant Pseudomonas aeruginosa isolates harboring bla GES-1 and bla GES-11 in Recife, Brazil, highlighting the spread of these genes and their role in conferring resistance to beta-lactams and carbapenems.
Detection of multidrug-resistant Pseudomonas aeruginosa harboring bla GES-1 and bla GES-11 in Recife, Brazil.
The study detected multidrug-resistant Pseudomonas aeruginosa isolates harboring bla GES-1 and bla GES-11 in Recife, Brazil, highlighting the spread of these genes and their role in conferring resistance to beta-lactams and carbapenems.
Functional Repertoire of Antibiotic Resistance Genes in Antibiotic Manufacturing Effluents and Receiving Freshwater Sediments.
The study identified numerous antibiotic resistance genes (ARGs) in antibiotic manufacturing effluents and receiving sediments, highlighting the presence of both known and potentially novel resistance mechanisms. Key findings include the discovery of macrolide resistance genes such as hflx, msr(e), mph(e), mph(g), and mef(c), as well as sulfonamide resistance genes sul1 and sul2, and beta-lactamase genes like bla ges-1, bla veb-9, and bla cm y-10. Additionally, trimethoprim resistance genes dfr14, dfra1, and dfr17 were identified.
Complete Genome Sequencing of Acinetobacter baumannii Strain K50 Discloses the Large Conjugative Plasmid pK50a Encoding Carbapenemase OXA-23 and Extended-Spectrum beta-lactamase GES-11.
The study identifies the carbapenemase OXA-23 and the extended-spectrum beta-lactamase GES-11 encoded on the large conjugative plasmid pK50a in Acinetobacter baumannii strain K50.
Characteristics of Carbapenemase-Producing Enterobacteriaceae in Wastewater Revealed by Genomic Analysis.
The study identified various carbapenemase-encoding genes, including bla GES-5, bla GES-6, bla GES-24, bla NDM-5, bla IMP-8, bla IMP-19, bla KPC-2, and bla VIM-1, in carbapenemase-producing Enterobacteriaceae (CPE) isolated from wastewater in Japan and Taiwan.
Characteristics of Carbapenemase-Producing Enterobacteriaceae in Wastewater Revealed by Genomic Analysis.
The study identified various carbapenemase-encoding genes, including bla GES-5, bla GES-6, bla GES-24, bla NDM-5, bla IMP-8, bla IMP-19, bla KPC-2, and bla VIM-1, in carbapenemase-producing Enterobacteriaceae (CPE) isolated from wastewater in Japan and Taiwan.
Characteristics of Carbapenemase-Producing Enterobacteriaceae in Wastewater Revealed by Genomic Analysis.
The study identified various carbapenemase-encoding genes, including bla GES-5, bla GES-6, bla GES-24, bla NDM-5, bla IMP-8, bla IMP-19, bla KPC-2, and bla VIM-1, in carbapenemase-producing Enterobacteriaceae (CPE) isolated from wastewater in Japan and Taiwan.
Spread of Plasmid-Encoded NDM-1 and GES-5 Carbapenemases among Extensively Drug-Resistant and Pandrug-Resistant Clinical Enterobacteriaceae in Durban, South Africa.
The study identifies the presence of blaNDM-1, blaGES-5, blaOXA-232, and blaNDM-5 in extensively drug-resistant and pandrug-resistant Enterobacteriaceae isolates in Durban, South Africa, highlighting the spread of plasmid-mediated carbapenem resistance.
P174E Substitution in GES-1 and GES-5 beta-lactamases Improves Catalytic Efficiency toward Carbapenems.
The P174E substitution in GES-1 and GES-5 beta-lactamases improves catalytic efficiency towards carbapenems, as evidenced by increased k_cat/K_m values and improved hydrolytic activity.
P174E Substitution in GES-1 and GES-5 beta-lactamases Improves Catalytic Efficiency toward Carbapenems.
The P174E substitution in GES-1 and GES-5 beta-lactamases improves catalytic efficiency towards carbapenems, as evidenced by increased k_cat/K_m values and improved hydrolytic activity.
Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS.
The study developed a MALDI-TOF MS-based ertapenem hydrolysis assay to rapidly detect carbapenemase activity in Enterobacteriaceae strains from positive blood cultures, identifying several carbapenemase genes including blaKPC, blaNDM, blaIMP, blaVIM, blaGES, and blaOXA-48.
Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.
The study evaluates the CIMplus test for rapid detection and characterization of carbapenemase-producing Enterobacteriaceae (CPE), demonstrating high sensitivity and specificity in identifying various carbapenemase types, including KPC, GES, NDM, VIM, IMP, OXA-48, and OXA-181.
Extensively drug-resistant (XDR) Pseudomonas aeruginosa identified in Lima, Peru co-expressing a VIM-2 metallo-β-lactamase, OXA-1 β-lactamase and GES-1 extended-spectrum β-lactamase.
The study identifies a multidrug-resistant Pseudomonas aeruginosa isolate from Peru that co-expresses the VIM-2 metallo-beta-lactamase, OXA-1 beta-lactamase, and GES-1 extended-spectrum beta-lactamase, highlighting the emergence of extensive drug resistance in the region.
Characterization of antimicrobial resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa carrying IMP variants recovered from a Mexican Hospital.
The study identifies three novel β-lactamase variants (bla GES-32, bla IMP-56, and bla IMP-62) within new class 1 integron configurations and detects two plasmids carrying bla IMP in a single P. aeruginosa strain. Mutations in the oprD gene, including stop codons and insertions, contribute to carbapenem resistance.
Acquisition of Extended-Spectrum beta-lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Pseudomonas aeruginosa.
The study identifies GES-6, an extended-spectrum beta-lactamase, as the cause of resistance to ceftolozane-tazobactam in Pseudomonas aeruginosa. GES-6 exhibits increased hydrolytic activity towards carbapenems and reduced susceptibility to beta-lactamase inhibitors compared to GES-1.
Molecular Epidemiology and Risk Factors of Carbapenemase-Producing Enterobacteriaceae Isolates in Portuguese Hospitals: Results From European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE).
The study identified the novel blaKPC-21 gene, along with blaGES-5 and blaGES-6, in carbapenem-resistant Enterobacteriaceae isolates in Portugal, highlighting the emergence of new carbapenemase variants and their association with high-risk clones.
Molecular Epidemiology and Risk Factors of Carbapenemase-Producing Enterobacteriaceae Isolates in Portuguese Hospitals: Results From European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE).
The study identified the novel blaKPC-21 gene, along with blaGES-5 and blaGES-6, in carbapenem-resistant Enterobacteriaceae isolates in Portugal, highlighting the emergence of new carbapenemase variants and their association with high-risk clones.
Development of a Novel Loop-Mediated Isothermal Amplification Method to Detect Guiana Extended-Spectrum (GES) beta-lactamase Genes in Pseudomonas aeruginosa.
The study developed a novel LAMP assay to detect blaGES and the G493A mutation, which confers carbapenem resistance in Pseudomonas aeruginosa.
Genotypic antimicrobial resistance assays for use on E. coli isolates and stool specimens.
The study developed and validated 85 PCR assays to detect 79 AMR genes and mutations associated with resistance across 10 antimicrobial classes, focusing on E. coli. The assays showed high concordance with sequencing and phenotypic susceptibility testing, demonstrating their potential for AMR surveillance in E. coli isolates and direct stool specimens.
Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa.
The study evaluated the synergy of ceftazidime-avibactam (CZA) in combination with other antibiotics against multidrug-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa. Several AMR genes, including blaKPC-2, blaKPC-3, blaCTX-M-15, and others, were identified as conferring resistance to CZA and other antibiotics.
Phenotypic and genotypic characterization of multi-drug-resistant Escherichia coli isolates harboring bla(CTX-M) group extended-spectrum beta-lactamases recovered from pediatric patients in Shenzhen, southern China.
The study identified various bla CTX-M subtypes, including bla CTX-M-15, bla CTX-M-14, bla CTX-M-90, and others, as well as bla TEM, bla SHV, bla GES, bla CARB, bla NDM-1, bla KPC, and mcr-1, which contribute to multidrug resistance in E. coli isolates from pediatric patients in Shenzhen, China.
Carbapenemase-producing Enterobacteriaceae and Aeromonas spp. present in wastewater treatment plant effluent and nearby surface waters in the US.
The study identifies various carbapenemase-producing bacteria, including Enterobacteriaceae and Aeromonas spp., in wastewater treatment plant effluent and nearby surface waters in the US. Key findings include the detection of bla KPC-2, bla KPC-3, bla NDM-1, bla NDM-5, bla NDM-7, bla GES-5, and bla VIM-1 genes in several bacterial species, highlighting the presence of clinically relevant carbapenem-resistant genotypes in the environment.
Metal impacts on the persistence and proliferation of β-lactam resistance genes in Xiangjiang River, China.
The study identifies and characterizes the persistence and proliferation of various β-lactam resistance genes (blaTEM, blaVIM, blaSHV, blaGES, blaDHA, blaOXA-1, blaOXA-2, blaOXA-10, blaCMY-2, and blaampC) in the Xiangjiang River, highlighting the impact of heavy metals on their distribution and the role of bacterial communities in their persistence.
Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum beta-lactamase Enzymes: A Newly Emerging Threat in the United States.
The study identifies two extensively drug-resistant Pseudomonas aeruginosa ST309 isolates harboring tandem GES-19 and GES-26 beta-lactamases, which confer resistance to all β-lactams, including novel combinations like ceftazidime/avibactam and ceftolozane/tazobactam. The tandem expression of GES enzymes in E. coli resulted in significant resistance, highlighting the potential threat of these isolates in the United States.
Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum beta-lactamase Enzymes: A Newly Emerging Threat in the United States.
The study identifies two extensively drug-resistant Pseudomonas aeruginosa ST309 isolates harboring tandem GES-19 and GES-26 beta-lactamases, which confer resistance to all β-lactams, including novel combinations like ceftazidime/avibactam and ceftolozane/tazobactam. The tandem expression of GES enzymes in E. coli resulted in significant resistance, highlighting the potential threat of these isolates in the United States.
Insights into the Periplasmic Proteins of Acinetobacter baumannii AB5075 and the Impact of Imipenem Exposure: A Proteomic Approach.
The study identifies several periplasmic proteins involved in antibiotic resistance in Acinetobacter baumannii AB5075, including the beta-lactamases AmpC, OXA-23, and GES-11, as well as the RND-type efflux pump AdeT. Additionally, a novel metal-dependent hydrolase, ABUW_0920, was identified, suggesting potential roles in beta-lactam resistance.
High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.
The exoU gene was associated with increased resistance to fluoroquinolones and aminoglycosides in Pseudomonas aeruginosa isolates.
Spatiotemporal dynamics of multidrug resistant bacteria on intensive care unit surfaces.
The study identified various AMR genes, including bla OXA-23, bla OXA-66, bla NDM-1, bla NDM-5, bla NDM-7, bla OXA-181, bla OXA-232, erm(B), vanA, msr(C), fosA, oqxA, aph(3')-lb, bla PAO, bla OXA-50, catB7, and bla GES-5, in multidrug-resistant bacteria isolated from ICU surfaces in Pakistan and the USA.
Dissemination of carbapenem-resistant Acinetobacter baumannii strains carrying the bla (GES), bla (NDM) and bla (OXA23) in Morocco.
The study identified the presence of blaOXA-23, blaGES, and blaNDM genes in carbapenem-resistant Acinetobacter baumannii strains in Morocco, highlighting the dissemination of these resistance mechanisms.
Environmental Presence and Genetic Characteristics of Carbapenemase-Producing Enterobacteriaceae from Hospital Sewage and River Water in the Philippines.
The study identified NDM, KPC, OXA-48-like, GES, and IMI carbapenemase genes in carbapenemase-producing Enterobacteriaceae (CPE) isolated from hospital sewage and river water in the Philippines. NDM was the most prevalent gene type, followed by KPC, OXA-48-like, GES, and IMI. Additionally, CTX-M-type ESBL and 16S rRNA methylase genes were also detected.
High-Risk International Clones of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Endemic to Indonesian Intensive Care Units: Impact of a Multifaceted Infection Control Intervention Analyzed at the Genomic Level.
The study identified several carbapenemase-encoding genes (blaGES-5, blaIMP-1, blaIMP-7, blaIMP-43, blaVIM-2, and blaVIM-8) and mutations in the porin gene oprD that contribute to carbapenem resistance in Pseudomonas aeruginosa isolates from Indonesian ICUs.
A Multispecies Cluster of GES-5 Carbapenemase-Producing Enterobacterales Linked by a Geographically Disseminated Plasmid.
The study identified a GES-5 carbapenemase-producing Klebsiella oxytoca cluster linked by a geographically disseminated IncQ plasmid, highlighting the importance of whole-genome sequencing in detecting rare resistance mechanisms.
Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany.
The study identified various carbapenemase genes including bla VIM-1, bla VIM-2, bla IMP-82, bla NDM-1, and bla GES-5 in carbapenem-resistant Pseudomonas aeruginosa isolates from three German medical centers.
Molecular epidemiology and antimicrobial resistance features of Acinetobacter baumannii clinical isolates from Pakistan.
The study identified multiple antimicrobial resistance genes in Acinetobacter baumannii isolates from Pakistan, including bla OXA-23, bla GES-11, aphA6a, aacA4, sul1, drfA7, msr(E), and mph(E). These genes contribute to resistance against various antibiotics such as carbapenems, cephalosporins, aminoglycosides, sulfonamides, and macrolides.
In Vivo Cross-Linking MS Reveals Conservation in OmpA Linkage to Different Classes of beta-lactamase Enzymes.
The study identifies blaGES-11 and Oxa23 as beta-lactamase enzymes that interact with the C-terminal domain of OmpA in Acinetobacter baumannii AB5075, contributing to resistance against various β-lactam antibiotics.
Targeting the Class A Carbapenemase GES-5 via Virtual Screening.
The study identifies four compounds that act as high micromolar competitive inhibitors of GES-5, a class A carbapenemase. These compounds show activity against GES-5 and, to a lesser extent, against KPC-2.
Development of a Two Triplex Real-Time Polymerase Chain Reaction for Rapid Detection of Six Carbapenemase Genes in Enterobacteriaceae.
The study developed a two triplex real-time PCR assay for the rapid detection of six carbapenemase genes (blaKPC, blaNDM, blaOXA-48_like, blaIMP, blaVIM, and blaGES) in Enterobacteriaceae, demonstrating 100% concordance with previously identified genotypes.
Rapid Detection of KPC-Producing Enterobacterales Susceptible to Imipenem/Relebactam by Using the MALDI-TOF MS MBT STAR-Carba IVD Assay.
The study presents a MALDI-TOF MS-based method for rapidly detecting KPC-producing Enterobacterales susceptible to imipenem/relebactam, showing high sensitivity and specificity.
Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.
The study evaluated the EDTA-modified carbapenem inactivation method (eCIM) for detecting metallo-β-lactamase-producing Pseudomonas aeruginosa. It found that eCIM effectively identified VIM, NDM, and GES-producing isolates, but failed to detect IMP and SPM-producing isolates. Modifications to the mCIM improved detection of GES-producing isolates.
High Level of Resistance to Antimicrobials and Heavy Metals in Multidrug-Resistant Pseudomonas sp. Isolated from Water Sources.
The study identified several AMR genes in multidrug-resistant Pseudomonas sp. isolates from water sources, including blaGES, qnrS, qepA, tetB, aac(3')-IIa, and ant(2'')-Ia, which confer resistance to various antibiotics.
Antimicrobial Resistance in Swine Fecal Specimens Across Different Farm Management Systems.
The study identified several AMR genes associated with different antimicrobial classes in swine fecal samples from farms with varying antimicrobial usage levels. These genes included beta-lactamases, aminoglycoside modifying enzymes, fluoroquinolone resistance genes, macrolide resistance markers, polymyxin resistance genes, phenicol resistance genes, and trimethoprim resistance genes.
Distribution of Class B and Class A β-Lactamases in Clinical Strains of Pseudomonas aeruginosa: Comparison of Phenotypic Methods and High-Resolution Melting Analysis (HRMA) Assay.
The study identified various β-lactamase genes, including bla SHV, bla TEM, bla KPC, bla IMP, bla VIM, and bla GES, in Pseudomonas aeruginosa isolates using HRMA assay. These genes were associated with resistance to multiple β-lactam antibiotics.
Evaluating the antimicrobial resistance patterns and molecular frequency of bla (oxa-48) and bla (GES-2) genes in Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from burn wound infection in Tehran, Iran.
The study identifies the molecular frequency of bla GES-2 and bla oxa-48 genes in Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from burn wound infections in Tehran, Iran. Both genes were found to be prevalent, contributing to resistance against cephalosporins.
Rapid Detection and Characterization of Carbapenemases in Enterobacterales with a New Modified Carbapenem Inactivation Method, mCIMplus.
The study evaluates the mCIMplus test for rapid detection and characterization of carbapenemases in Enterobacterales, demonstrating high sensitivity and specificity for various carbapenemase types including OXA-48-like, NDM, KPC, VIM, GES-5, and IMP-1.
High Colonization Rate and Heterogeneity of ESBL- and Carbapenemase-Producing Enterobacteriaceae Isolated from Gull Feces in Lisbon, Portugal.
The study identified various ESBL and carbapenemase-producing Enterobacteriaceae in gull feces, including OXA-181, OXA-48, KPC-2, KPC-3, GES-5, GES-6, and multiple CTX-M variants. These findings highlight the role of gulls as potential reservoirs for multidrug-resistant bacteria.
High Colonization Rate and Heterogeneity of ESBL- and Carbapenemase-Producing Enterobacteriaceae Isolated from Gull Feces in Lisbon, Portugal.
The study identified various ESBL and carbapenemase-producing Enterobacteriaceae in gull feces, including OXA-181, OXA-48, KPC-2, KPC-3, GES-5, GES-6, and multiple CTX-M variants. These findings highlight the role of gulls as potential reservoirs for multidrug-resistant bacteria.
First Detection of GES-5-Producing Escherichia coli from Livestock-An Increasing Diversity of Carbapenemases Recognized from German Pig Production.
The study reports the first detection of GES-5-producing Escherichia coli from livestock, highlighting the emergence of diverse carbapenemases in German pig production.
First Detection of GES-5-Producing Escherichia coli from Livestock-An Increasing Diversity of Carbapenemases Recognized from German Pig Production.
The study reports the first detection of GES-5-producing Escherichia coli from livestock, highlighting the emergence of diverse carbapenemases in German pig production.
First Detection of GES-5-Producing Escherichia coli from Livestock-An Increasing Diversity of Carbapenemases Recognized from German Pig Production.
The study reports the first detection of GES-5-producing Escherichia coli from livestock, highlighting the emergence of diverse carbapenemases in German pig production.
Evaluation of the Xpert Carba-R NxG Assay for Detection of Carbapenemase Genes in a Global Challenge Set of Pseudomonas aeruginosa Isolates.
The Xpert Carba-R NxG assay effectively detects various carbapenemase genes, including blaVIM, blaIMP, blaNDM, blaSPM, blaKPC, and blaGES, in Pseudomonas aeruginosa isolates.
Antibiogram and Genetic Characterization of Carbapenem-Resistant Gram-Negative Pathogens Incriminated in Healthcare-Associated Infections.
The study identified bla KPC and bla GES genes as the primary contributors to carbapenem resistance in Gram-negative pathogens, with high prevalence among the tested isolates.
Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study.
The study identifies multiple mechanisms of resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa, including the production of extended-spectrum beta-lactamases (ESBLs) and carbapenemases, overproduction of the intrinsic cephalosporinase PDC, and mutations in regulatory and peptidoglycan recycling genes.
Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study.
The study identifies multiple mechanisms of resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa, including the production of extended-spectrum beta-lactamases (ESBLs) and carbapenemases, overproduction of the intrinsic cephalosporinase PDC, and mutations in regulatory and peptidoglycan recycling genes.
Extended Spectrum Beta-Lactamase-Resistant Determinants among Carbapenem-Resistant Enterobacteriaceae from Beef Cattle in the North West Province, South Africa: A Critical Assessment of Their Possible Public Health Implications.
The study identified various carbapenemase and ESBL genes in carbapenem-resistant Enterobacteriaceae isolated from beef cattle in South Africa, highlighting the presence of resistance determinants that could pose public health risks.
Exploring antibiotic resistance in environmental integron-cassettes through intI-attC amplicons deep sequencing.
The study identified several antibiotic resistance genes (ARGs) in environmental integron-cassettes from the Velhas River, including clinically relevant genes such as blaGES-5, aacA7, dfrA21, qacH, emrE, fosB3, and novA. These genes were associated with various resistance mechanisms, primarily efflux pumps and inactivation.
Occurrence, identification, and antibiogram signatures of selected Enterobacteriaceae from Tsomo and Tyhume rivers in the Eastern Cape Province, Republic of South Africa.
The study identified various beta-lactamase genes (bla TEM, bla CTX-M, bla SHV, bla OXA-1-like, bla PER, bla VIM, bla IMP, bla KPC, bla GES, bla OXA-48-like), plasmid-mediated AmpC beta-lactamase genes (bla EBC, bla ACC, bla FOX, bla CIT), tetracycline resistance genes (tetA, tetB, tetD, tetM), chloramphenicol resistance gene (catII), and sulfonamide resistance gene (sulII) in Enterobacteriaceae isolates from Tsomo and Tyhume rivers.
First report of bla GES-1 in Proteus mirabilis clinical isolates.
The study reports the first detection of bla GES-1 in Proteus mirabilis clinical isolates, highlighting the emergence of this resistance gene in a species not previously associated with it.
Acinetobacter baumannii Antibiotic Resistance Mechanisms.
The paper reviews various beta-lactamases and other resistance mechanisms in Acinetobacter baumannii, focusing on their roles in resistance to beta-lactams, aminoglycosides, and other antibiotics.
Acinetobacter baumannii Antibiotic Resistance Mechanisms.
The paper reviews various beta-lactamases and other resistance mechanisms in Acinetobacter baumannii, focusing on their roles in resistance to beta-lactams, aminoglycosides, and other antibiotics.
Acinetobacter baumannii Antibiotic Resistance Mechanisms.
The paper reviews various beta-lactamases and other resistance mechanisms in Acinetobacter baumannii, focusing on their roles in resistance to beta-lactams, aminoglycosides, and other antibiotics.
Isolation Procedure for CP E. coli from Caeca Samples under Review towards an Increased Sensitivity.
The study characterizes several carbapenemase genes (bla VIM-1, bla GES-5, bla KPC-2, bla NDM-1, and bla OXA-48) in CP E. coli isolates from caeca samples, highlighting their role in carbapenem resistance and evaluating improved isolation methods for better detection.
Molecular Epidemiology of Human Papillomaviruses, Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium among Female Sex Workers in Burkina Faso: Prevalence, Coinfections and Drug Resistance Genes.
The study identified several antibiotic resistance genes, including bla QNR B, bla GES, bla SHV, bla CTX-M, and bla QNR S, in Neisseria gonorrhoeae, Chlamydia trachomatis, and Mycoplasma genitalium among female sex workers in Burkina Faso.
In Vivo Evolution of GES β-Lactamases Driven by Ceftazidime/Avibactam Treatment of Pseudomonas aeruginosa Infections.
The study shows that a single amino acid substitution (P162S) in bla GES-5 leads to the formation of bla GES-15, which reverts the carbapenemase phenotype of GES-5 back to the ESBL phenotype of GES-1, demonstrating the dynamic nature of β-lactamase evolution in response to antibiotic pressure.
In Vivo Evolution of GES β-Lactamases Driven by Ceftazidime/Avibactam Treatment of Pseudomonas aeruginosa Infections.
The study shows that a single amino acid substitution (P162S) in bla GES-5 leads to the formation of bla GES-15, which reverts the carbapenemase phenotype of GES-5 back to the ESBL phenotype of GES-1, demonstrating the dynamic nature of β-lactamase evolution in response to antibiotic pressure.
In Vivo Evolution of GES β-Lactamases Driven by Ceftazidime/Avibactam Treatment of Pseudomonas aeruginosa Infections.
In Vivo Evolution of GES β-Lactamases Driven by Ceftazidime/Avibactam Treatment of Pseudomonas aeruginosa Infections.
In Vivo Evolution of GES β-Lactamases Driven by Ceftazidime/Avibactam Treatment of Pseudomonas aeruginosa Infections.
Improved molecular characterization of the Klebsiella oxytoca complex reveals the prevalence of the kleboxymycin biosynthetic gene cluster.
The study identified the kleboxymycin biosynthetic gene cluster (BGC) in various species of the Klebsiella oxytoca complex, including K. michiganensis, K. grimontii, K. oxytoca, and K. pasteurii. The BGC was found to be prevalent in clinical and gut-associated isolates, suggesting its potential role in virulence.
Detection of Extended-Spectrum beta-lactamases among Acinetobacter Baumannii Isolated from Hospitals of Qazvin, Iran.
The study identified the presence of blaOXA-1, blaTEM-1, blaGES-1, blaCTX-M-15, and blaPER-1 genes in ESBL-producing Acinetobacter baumannii isolates in Qazvin, Iran. These genes were found to confer resistance to various β-lactam antibiotics.
Dissemination of carbapenem resistance and plasmids encoding carbapenemases in Gram-negative bacteria isolated in India.
The study identifies various carbapenem resistance genes, including blaNDM-1, blaOXA-181, blaGES-1, blaGES-9, blaOXA-23, blaOXA-51, and blaIMP-1, in Gram-negative bacteria from India. These genes were found to confer resistance to meropenem and imipenem.
Dissemination of carbapenem resistance and plasmids encoding carbapenemases in Gram-negative bacteria isolated in India.
The study identifies various carbapenem resistance genes, including blaNDM-1, blaOXA-181, blaGES-1, blaGES-9, blaOXA-23, blaOXA-51, and blaIMP-1, in Gram-negative bacteria from India. These genes were found to confer resistance to meropenem and imipenem.
Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore.
The study identified multiple carbapenemase genes (blaIMP, blaNDM-1, blaVIM, blaGES-5, blaKPC-2) and chromosomal mutations (ampD, ampR, dacB, mexZ, armZ, nalD, oprD, gyrA, parC) associated with carbapenem resistance in Pseudomonas aeruginosa isolates from Singapore.
Virulence and Antibiotic Resistance Characteristics of Vibrio Isolates From Rustic Environmental Freshwaters.
The study identified several antibiotic resistance genes in Vibrio isolates from environmental freshwater sources, including aadA, strA, aphA1, catII, ampC, blaTEM, blaGES, blaOXA-48, blaIMP, blaVIM, blaKPC, and qnrVC, indicating a significant risk of antimicrobial resistance in these bacteria.
Prevalence and characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from raw vegetables retailed in Southern Thailand.
The study identified the prevalence of ESBL-producing E. coli and K. pneumoniae in raw vegetables in Southern Thailand, highlighting the presence of bla SHV as the most common ESBL-encoding gene, along with bla TEM, bla CTX-M1, and bla CTX-M9.
Histone-like nucleoid-structuring protein (H-NS) regulatory role in antibiotic resistance in Acinetobacter baumannii.
The study shows that H-NS regulates the expression of antibiotic resistance genes in Acinetobacter baumannii, leading to increased resistance to beta-lactam antibiotics, aminoglycosides, quinolones, chloramphenicol, trimethoprim, sulfonamides, and colistin.
Geographic Patterns of Carbapenem-Resistant Pseudomonas aeruginosa in the Asia-Pacific Region: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) Program, 2015-2019.
The study identified various carbapenemase genes, including blaVIM, blaNDM, blaVEB, blaIMP, blaGES, blaTEM, and blaKPC, in carbapenem-resistant Pseudomonas aeruginosa isolates from the Asia-Pacific region.
Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Strains Isolated at the German Military Field Laboratory in Mazar-e Sharif, Afghanistan.
The study identified bla OXA-23 as the primary cause of carbapenem resistance in Acinetobacter baumannii isolates from Afghanistan, along with various other resistance genes for sulfonamides, macrolides, tetracyclines, and aminoglycosides.
Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
Disruption of DsbA-mediated disulfide bond formation incapacitates diverse β-lactamases and destabilizes mobile colistin resistance enzymes. Chemical inhibition of DsbA sensitizes multidrug-resistant clinical isolates to existing antibiotics.
Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
Disruption of DsbA-mediated disulfide bond formation incapacitates diverse β-lactamases and destabilizes mobile colistin resistance enzymes. Chemical inhibition of DsbA sensitizes multidrug-resistant clinical isolates to existing antibiotics.
Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
Disruption of DsbA-mediated disulfide bond formation incapacitates diverse β-lactamases and destabilizes mobile colistin resistance enzymes. Chemical inhibition of DsbA sensitizes multidrug-resistant clinical isolates to existing antibiotics.
Genetic Dissection of Antibiotic Adjuvant Activity.
The study identifies GES-14 and OXA-23 beta-lactamases as key resistance determinants for ceftazidime and meropenem in Acinetobacter baumannii AB5075, along with lptE and dsbA contributing to meropenem resistance.
Genomic Characterization of Carbapenem-Non-susceptible Pseudomonas aeruginosa Clinical Isolates From Saudi Arabia Revealed a Global Dissemination of GES-5-Producing ST235 and VIM-2-Producing ST233 Sub-Lineages.
The study identified GES-5-producing ST235 and VIM-2-producing ST233 sub-lineages of Pseudomonas aeruginosa in Saudi Arabia, highlighting their global dissemination and the presence of various resistance genes including blaGES-5, blaVIM-2, and others.
Major Bloodstream Infection-Causing Bacterial Pathogens and Their Antimicrobial Resistance in South Korea, 2017-2019: Phase I Report From Kor-GLASS.
The study identified several AMR genes, including bla CTX-M–27, vanA, bla OXA–23, bla KPC, bla NDM–5, bla OXA–181, bla DHA–1, bla CMY–2, and mecA, which contribute to resistance against various antibiotics in bloodstream infection-causing pathogens in South Korea.
Evaluation of the VITEK2 AST-XN17 card for the detection of carbapenemase-producing Enterobacterales in isolates primarily producing metallo β-lactamase.
The study evaluates the effectiveness of the VITEK2 AST-XN17 card in detecting carbapenemase-producing Enterobacterales (CPE) and identifies several carbapenemase genes, including blaIMP-6, blaIMP-1, blaIMP-34, blaGES-4, and others, which confer resistance to carbapenems.
Genomic characterisation of three GES-producing Enterobacterales isolated in the Czech Republic
Three GES-producing Enterobacterales isolates were characterized, including novel variants of blaGES and a new blaOXA-1011 gene associated with carbapenem resistance.
Genomic characterisation of three GES-producing Enterobacterales isolated in the Czech Republic
Three GES-producing Enterobacterales isolates were characterized, including novel variants of blaGES and a new blaOXA-1011 gene associated with carbapenem resistance.
Genomic characterisation of three GES-producing Enterobacterales isolated in the Czech Republic
Three GES-producing Enterobacterales isolates were characterized, including novel variants of blaGES and a new blaOXA-1011 gene associated with carbapenem resistance.
Prolonged Outbreak of Carbapenem and Colistin-Resistant Klebsiella pneumoniae at a Large Tertiary Hospital in Brazil.
Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant beta-lactamases and Their Increasing Importance.
Two extensively drug-resistant Pseudomonas aeruginosa isolates were found to possess inhibitor-resistant GES beta-lactamases, intrinsic PDC and OXA beta-lactamases, and disruptions in the OprD porin, contributing to imipenem/relebactam resistance.
β-Lactam Antibiotics and beta-lactamase Enzymes Inhibitors, Part 2: Our Limited Resources.
The paper reviews β-lactam antibiotics and beta-lactamase enzymes inhibitors, focusing on the mechanisms of resistance mediated by beta-lactamases such as TEM-1, SHV-1, KPC-2, OXA-48, and NDM-1, and highlights the need for new inhibitors to combat carbapenem-resistant bacteria.
Combination of phage therapy and cefiderocol to successfully treat Pseudomonas aeruginosa cranial osteomyelitis.
The study identifies the presence of the blaGES-1 gene and MDR efflux pumps MexD and MexX in multidrug-resistant P. aeruginosa isolates, which contribute to resistance against various β-lactam antibiotics. Phage therapy in combination with cefiderocol was successful in treating the infection.
KPC-3-, GES-5-, and VIM-1-Producing Enterobacterales Isolated from Urban Ponds.
The study identified bla KPC-3, bla GES-5, and bla VIM genes in various Enterobacterales isolates from urban ponds, highlighting their role in carbapenem resistance.
Genomic Surveillance of Clinical Pseudomonas aeruginosa Isolates Reveals an Additive Effect of Carbapenemase Production on Carbapenem Resistance.
The study identified several beta-lactamase genes, including bla OXA-50, bla OXA-10, bla OXA-488, bla GES-5, bla IMP-1, bla IMP-10, bla NDM-1, bla VIM-2, bla VIM-6, and bla VIM-11, as well as inactivating mutations in the porin gene oprD, which contribute to carbapenem resistance in Pseudomonas aeruginosa isolates from Pakistan.
Genomic Analysis of Carbapenem-Resistant Comamonas in Water Matrices: Implications for Public Health and Wastewater Treatments.
The study identifies carbapenem-resistant Comamonas denitrificans isolates carrying genomic islands encoding carbapenemase blaGES-5 and extended-spectrum beta-lactamase blaOXA alleles, along with aminoglycoside resistance genes aadA and detergent resistance gene qacL.
Wastewater Surveillance Detected Carbapenemase Enzymes in Clinically Relevant Gram-Negative Bacteria in Helsinki, Finland; 2011-2012.
The study identified carbapenemase genes bla GES, bla KPC, and bla VIM in clinically relevant gram-negative bacteria in wastewater samples from Helsinki, Finland, highlighting the significance of wastewater surveillance in tracking antimicrobial resistance.
Isolation and Identification of Escherichia coli and Klebsiella pneumoniae Strains Resistant to the Oxyimino-Cephalosporins and the Monobactam by Production of GES Type Extended Spectrum Bêta-Lactamase (ESBL) at Saint Camille Hospital Center in Ouagadougou, Burkina Faso.
The study identified the presence of the GES gene in Escherichia coli and Klebsiella pneumoniae strains resistant to oxyimino-cephalosporins and monobactam in Burkina Faso.
Association of Carbapenemase-Producing Enterobacterales Detected in Stream and Clinical Samples.
The study identified carbapenemase genes such as bla KPC-2, bla KPC-3, bla NDM-1, bla NDM-5, bla GES-5, bla GES-6, and bla OXA-48 in carbapenem-resistant Enterobacterales (CRE) isolates from streams and clinical samples in Korea. These genes were associated with resistance to carbapenems, and certain sequence types (STs) were shared between environmental and clinical isolates.
Association of Carbapenemase-Producing Enterobacterales Detected in Stream and Clinical Samples.
The study identified carbapenemase genes such as bla KPC-2, bla KPC-3, bla NDM-1, bla NDM-5, bla GES-5, bla GES-6, and bla OXA-48 in carbapenem-resistant Enterobacterales (CRE) isolates from streams and clinical samples in Korea. These genes were associated with resistance to carbapenems, and certain sequence types (STs) were shared between environmental and clinical isolates.
Novel Insights into bla(GES) Mobilome Reveal Extensive Genetic Variation in Hospital Effluents.
The study identifies various bla(GES) variants in Aeromonas and Klebsiella isolates from hospital effluents, highlighting their role in carbapenem resistance and the genetic diversity of these resistance determinants.
High prevalence of bla(VEB), bla(GES) and bla(PER) genes in beta-lactam resistant clinical isolates of Pseudomonas aeruginosa.
The study identified the high prevalence of bla(VEB), bla(GES), and bla(PER) genes in beta-lactam-resistant Pseudomonas aeruginosa clinical isolates, highlighting their significant role in resistance to various beta-lactam antibiotics.
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC's Emerging Infections Program, United States, 2016-2018.
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC's Emerging Infections Program, United States, 2016-2018.
Evaluation of the EasyScreen™ ESBL/CPO Detection Kit for the Detection of ß-Lactam Resistance Genes.
The EasyScreen™ ESBL/CPO Detection Kit effectively detects various β-lactam resistance genes, including bla VIM, bla NDM, bla IMP, bla OXA-48, bla KPC, bla OXA-23, bla OXA-51, bla SME, bla IMI, bla GES, bla TEM, bla SHV, bla CTX-M, bla CMY, bla DHA, and the mcr-1 gene, demonstrating high sensitivity and specificity for carbapenemase and ESBL detection in Enterobacterales, Pseudomonas spp., and Acinetobacter spp.
Molecular epidemiology and antimicrobial susceptibility of Pseudomonas spp. and Acinetobacter spp. from clinical samples at Jimja medical center, Ethiopia.
The study identified various AMR genes including bla OXA-486, bla CTX-M-15, bla OXA-51-like, bla OXA-69, bla GES-11, and bla NDM-1 in Pseudomonas and Acinetobacter isolates, highlighting the prevalence of multidrug-resistant strains in Ethiopia.
Genome-wide analysis reveals the emergence of multidrug resistant Stenotrophomonas acidaminiphila strain SINDOREI isolated from a patient with sepsis.
The study identifies multiple antibiotic resistance genes in the multidrug-resistant Stenotrophomonas acidaminiphila strain SINDOREI, including sul1, sul2, qnr, GES-1, aadA3, qacL, cmlA5, and tetC, which confer resistance to trimethoprim/sulfamethoxazole, fluoroquinolone, beta-lactam, aminoglycoside, disinfecting agents, phenicol, and tetracycline.
Emergence of a Novel Lineage and Wide Spread of a bla(CTX-M-15)/IncHI2/ST1 Plasmid among Nosocomial Enterobacter in Guadeloupe.
The study identifies the bla CTX-M-15 gene as the most prevalent ESBL determinant in ESBL-producing Enterobacter cloacae complex isolates, along with the IncHI2/ST1 plasmid. It also reports the presence of other resistance genes such as mcr-9, aac(3)-IIa, aac(6′)-Ib-cr, aph(3″)-Ib, aph(6)-Id, bla OXA-1, bla TEM-1B, qnrB1, fosA, sul2, tet(A), dfrA14, ars, mer, tni, and the ter operon.
Beta-lactamase determinants and molecular typing of carbapenem-resistant classic and hypervirulent Klebsiella pneumoniae clinical isolates from southwest of Iran.
The study identified several beta-lactamase genes, including bla NDM, bla IMP, bla VIM, bla GES, bla OXA-48-like, bla CTX-M, bla SHV, bla TEM, bla FOX, bla DHA, bla CMY, bla LAT, and bla ACT, which are responsible for carbapenem resistance in Klebsiella pneumoniae isolates from southwest Iran.
Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Tertiary Hospital in Northern China.
The study identified bla KPC-2, bla GES, bla NDM-1, and bla IMP as the main carbapenemase genes in CRKP isolates. Additionally, various ESBL genes, aminoglycoside resistance genes, and PMQR genes were detected.
Validation and Application of Long-Read Whole-Genome Sequencing for Antimicrobial Resistance Gene Detection and Antimicrobial Susceptibility Testing.
The study validated the use of long-read whole-genome sequencing for detecting antimicrobial resistance genes and predicting antimicrobial susceptibility. Several beta-lactamase and carbapenemase genes were identified in various bacterial isolates, demonstrating their role in resistance to specific antibiotics.
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii with Special Reference to Carbapenemases: A Systematic Review.
The paper reviews the molecular characteristics of carbapenem-resistant Acinetobacter baumannii, focusing on carbapenemases. It identifies several beta-lactamase genes, including OXA-23, OXA-51, OXA-58, VIM, NDM, IMP, KPC, and GES, which confer resistance to carbapenems. The study highlights the role of mobile genetic elements in the dissemination of these resistance genes.
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii with Special Reference to Carbapenemases: A Systematic Review.
The paper reviews the molecular characteristics of carbapenem-resistant Acinetobacter baumannii, focusing on carbapenemases. It identifies several beta-lactamase genes, including OXA-23, OXA-51, OXA-58, VIM, NDM, IMP, KPC, and GES, which confer resistance to carbapenems. The study highlights the role of mobile genetic elements in the dissemination of these resistance genes.
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii with Special Reference to Carbapenemases: A Systematic Review.
The paper reviews the molecular characteristics of carbapenem-resistant Acinetobacter baumannii, focusing on carbapenemases. It identifies several beta-lactamase genes, including OXA-23, OXA-51, OXA-58, VIM, NDM, IMP, KPC, and GES, which confer resistance to carbapenems. The study highlights the role of mobile genetic elements in the dissemination of these resistance genes.
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii with Special Reference to Carbapenemases: A Systematic Review.
The paper reviews the molecular characteristics of carbapenem-resistant Acinetobacter baumannii, focusing on carbapenemases. It identifies several beta-lactamase genes, including OXA-23, OXA-51, OXA-58, VIM, NDM, IMP, KPC, and GES, which confer resistance to carbapenems. The study highlights the role of mobile genetic elements in the dissemination of these resistance genes.
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii with Special Reference to Carbapenemases: A Systematic Review.
The paper reviews the molecular characteristics of carbapenem-resistant Acinetobacter baumannii, focusing on carbapenemases. It identifies several beta-lactamase genes, including OXA-23, OXA-51, OXA-58, VIM, NDM, IMP, KPC, and GES, which confer resistance to carbapenems. The study highlights the role of mobile genetic elements in the dissemination of these resistance genes.
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii with Special Reference to Carbapenemases: A Systematic Review.
The paper reviews the molecular characteristics of carbapenem-resistant Acinetobacter baumannii, focusing on carbapenemases. It identifies several beta-lactamase genes, including OXA-23, OXA-51, OXA-58, VIM, NDM, IMP, KPC, and GES, which confer resistance to carbapenems. The study highlights the role of mobile genetic elements in the dissemination of these resistance genes.
Expanded catalogue of metagenome-assembled genomes reveals resistome characteristics and athletic performance-associated microbes in horse.
The study identified a diverse array of antibiotic resistance genes (ARG) in the horse gut microbiome, highlighting the widespread use of antibiotics in horse management. The resistome characteristics were analyzed alongside the identification of microbes associated with athletic performance.
A 10-year microbiological study of Pseudomonas aeruginosa strains revealed the circulation of populations resistant to both carbapenems and quaternary ammonium compounds.
The study identified blaVIM-2 and blaGES-5 as carbapenem resistance genes and the overexpression of the MexAB-OprM efflux pump as a mechanism for resistance to DDAC in Pseudomonas aeruginosa.
Correlations among Antibiotic Resistance Genes, Mobile Genetic Elements and Microbial Communities in Municipal Sewage Treatment Plants Revealed by High-Throughput Sequencing.
The study identifies various tetracycline resistance genes (tetC, tetE, tetG, tetM, tetO, tetQ, tetW, tetX), sulfonamide resistance gene (sulI), aminoglycoside resistance genes (ant(2')-Ia, ant(3')-Ia, aph(6')-Id, aph(33')-Ib, aac(6')-Ib), beta-lactam resistance genes (blaGES, blaVEB), chloramphenicol resistance gene (catB3), MLS resistance genes (ereA, ermB), and multidrug resistance genes (acrB, mexB, mexF) in municipal sewage treatment plants, highlighting their association with mobile genetic elements and microbial communities.
Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals.
The study identifies multiple AMR genes and mutations contributing to CZA resistance in Enterobacterales and P. aeruginosa, including MBLs, blaKPC, blaVIM, blaIMP, blaNDM, blaSPM-1, and various mutations in genes related to efflux pumps, porins, and beta-lactamases.
Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals.
The study identifies multiple AMR genes and mutations contributing to CZA resistance in Enterobacterales and P. aeruginosa, including MBLs, blaKPC, blaVIM, blaIMP, blaNDM, blaSPM-1, and various mutations in genes related to efflux pumps, porins, and beta-lactamases.
High prevalence of extensively drug resistant and extended spectrum beta lactamases (ESBLs) producing uropathogenic Escherichia coli isolated from Faisalabad, Pakistan.
The study identified several ESBL genes including TEM-1, CTX-M1, CTX-M15, OXA-1, KPC, VIM, and GES in uropathogenic E. coli isolates from Faisalabad, Pakistan. These genes were associated with resistance to various beta-lactam antibiotics, highlighting the high prevalence of multidrug-resistant strains.
Characterization of Third Generation Cephalosporin- and Carbapenem-Resistant Aeromonas Isolates from Municipal and Hospital Wastewater.
The study identified several carbapenemase and ESBL genes in Aeromonas isolates from wastewater, highlighting the presence of bla KPC-2, bla VIM-2, bla OXA-48, bla IMP-13, bla GES-5, and bla MOX as significant contributors to antibiotic resistance.
Epidemiological and Genetic Characteristics of Clinical Carbapenem-Resistant Pseudomonas aeruginosa Strains in Guangdong Province, China.
The study identified blaIMP-45 as a major determinant of meropenem resistance in P. aeruginosa, and mutations in oprD, mexR, nalD, and armR were associated with meropenem resistance.
Phylogenomics of Globally Spread Clonal Groups 14 and 15 of Klebsiella pneumoniae.
The study characterizes various AMR genes and mutations in K. pneumoniae clonal groups 14 and 15, highlighting the prevalence of bla CTX-M-15, bla OXA-232, bla NDM-1, and other beta-lactamases, along with quinolone resistance mechanisms.
Investigating and Treating a Corneal Ulcer Due to Extensively Drug-Resistant Pseudomonas aeruginosa.
The study identifies the presence of blaVIM-80 and blaGES-9 in an extensively drug-resistant Pseudomonas aeruginosa isolate causing a corneal ulcer, highlighting their role in carbapenem resistance.
Hospital and community wastewater as a source of multidrug-resistant ESBL-producing Escherichia coli.
The study identifies several AMR genes, including bla CTX-M-15, bla CTX-M-14, bla CTX-M-27, bla CTX-M-1, bla GES-5, bla OXA-244, qnrS1, qnrB4, aac(3)-IId, aph(3'')-Ib, aph(6)-Id, catA1, cmlA1, and bla TEM-1, which confer resistance to various antibiotics in multidrug-resistant ESBL-producing E. coli isolates from hospital and environmental sources.
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program.
The study identified various beta-lactamase genes, including bla GES, bla VEB-9, bla PER-1, bla NDM-1, bla VIM-2, bla IMP-15, and bla IMP-18, as well as PDC variants like bla PDC-3 and bla PDC-19A, which contribute to resistance against ceftolozane-tazobactam and ceftazidime-avibactam in multidrug-resistant and carbapenem-resistant Pseudomonas aeruginosa isolates.
Antimicrobial resistance and mechanisms of epigenetic regulation.
The paper discusses the role of epigenetic modifications, such as DNA methylation, histone modification, and RNA methylation, in antimicrobial resistance. It highlights how these mechanisms contribute to bacterial adaptation and resistance to antibiotics.
Novel evidence on sepsis-inducing pathogens: from laboratory to bedside.
The paper discusses the epidemiology, virulence factors, host factors, and treatment options for sepsis-inducing pathogens, including E. coli, K. pneumoniae, S. aureus, P. aeruginosa, and S. pyogenes. It highlights the importance of understanding resistance mechanisms and the need for targeted therapies.
CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases.
The study presents a LAMP-CRISPR-Cas13a-based assay for the accurate detection of OXA-48 and GES carbapenemases in clinical samples, demonstrating 100% specificity and sensitivity.
Acinetobacter baumannii Global Clone-Specific Resistomes Explored in Clinical Isolates Recovered from Egypt.
The study identified several AMR genes and mutations in Acinetobacter baumannii isolates from Egypt, including blaOXA-23, ISAb1-amplified_blaADC, blaNDM-1, blaGES-11, armA, aac(6')-Ib9, aph(3')-VI, and sul1, along with mutations in adeS, baeS, and carO contributing to tigecycline and carbapenem resistance.
Acinetobacter baumannii: A multidrug-resistant pathogen, has emerged in Saudi Arabia.
The study highlights the emergence of multidrug-resistant Acinetobacter baumannii in Saudi Arabia, emphasizing the role of beta-lactamases such as blaOXA-23, blaOXA-24/40, and GES-5 in carbapenem resistance.
Acinetobacter baumannii: A multidrug-resistant pathogen, has emerged in Saudi Arabia.
The study highlights the emergence of multidrug-resistant Acinetobacter baumannii in Saudi Arabia, emphasizing the role of beta-lactamases such as blaOXA-23, blaOXA-24/40, and GES-5 in carbapenem resistance.
Screening for Resistant Bacteria, Antimicrobial Resistance Genes, Sexually Transmitted Infections and Schistosoma spp. in Tissue Samples from Predominantly Vaginally Delivered Placentae in Ivory Coast and Ghana.
The study identified multiple beta-lactamase genes, including bla CTX-M, bla IMP, bla GES, bla VIM, bla OXA-58-like, bla NDM, bla OXA-23-like, bla OXA-48-like, and bla KPC, in placental tissue samples from Ivory Coast and Ghana. These genes confer resistance to various beta-lactam antibiotics, indicating a high prevalence of antimicrobial resistance in the studied region.
Novel insights into genetic characteristics of bla(GES)-encoding plasmids from hospital sewage.
The study characterizes bla GES -encoding plasmids from hospital sewage, identifying bla GES-24, bla GES-6, and bla GES-5 genes, which confer resistance to carbapenems. These plasmids show diverse genetic contexts and are associated with various bacterial species.
Novel insights into genetic characteristics of bla(GES)-encoding plasmids from hospital sewage.
The study characterizes bla GES -encoding plasmids from hospital sewage, identifying bla GES-24, bla GES-6, and bla GES-5 genes, which confer resistance to carbapenems. These plasmids show diverse genetic contexts and are associated with various bacterial species.
Novel insights into genetic characteristics of bla(GES)-encoding plasmids from hospital sewage.
The study characterizes bla GES -encoding plasmids from hospital sewage, identifying bla GES-24, bla GES-6, and bla GES-5 genes, which confer resistance to carbapenems. These plasmids show diverse genetic contexts and are associated with various bacterial species.
Impact of acquired broad-spectrum beta-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam beta-lactamase inhibitors in Escherichia coli.
The study evaluates the impact of various beta-lactamases on the susceptibility of Escherichia coli to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) and their combinations with beta-lactamase inhibitors avibactam and taniborbactam.
Impact of acquired broad-spectrum beta-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam beta-lactamase inhibitors in Escherichia coli.
The study evaluates the impact of various beta-lactamases on the susceptibility of Escherichia coli to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) and their combinations with beta-lactamase inhibitors avibactam and taniborbactam.
Impact of acquired broad-spectrum beta-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam beta-lactamase inhibitors in Escherichia coli.
The study evaluates the impact of various beta-lactamases on the susceptibility of Escherichia coli to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) and their combinations with beta-lactamase inhibitors avibactam and taniborbactam.
Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli.
The study evaluated the performance of NG-Test CARBA 5, Xpert Carba-R, and carbapenem inactivation methods for identifying carbapenemases in non-fermenting Gram-negative bacilli. It found that NG-Test CARBA 5 showed good performance for carbapenemase detection in Pseudomonas aeruginosa but had issues with false positives for IMP in Acinetobacter baumannii.
Uncovering the Resistance Mechanisms in Extended-Drug-Resistant Pseudomonas aeruginosa Clinical Isolates: Insights from Gene Expression and Phenotypic Tests.
The study identified bla GES-2, bla OXA48-like, bla NDM, bla SPM, and bla VIM as the main carbapenemase genes in MDR P. aeruginosa isolates. Overexpression of mex efflux pumps, particularly mex C, was strongly associated with multidrug resistance.
bla (KPC-2) overexpression and bla (GES-5) carriage as major imipenem/relebactam resistance mechanisms in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively, in China.
The study identifies blaKPC-2 overexpression and blaGES-5 carriage as major mechanisms of imipenem/relebactam resistance in Pseudomonas aeruginosa high-risk clones ST463 and ST235, respectively.
Clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae in pediatric inpatients in South China.
The study identified blaNDM-5, blaNDM-1, blaIMP-4, and blaKPC-2 as the most prevalent carbapenemase genes in CRE isolates from pediatric inpatients in South China.
Acquired bla(VIM) and bla(GES) Carbapenemase-Encoding Genes in Pseudomonas aeruginosa: A Seven-Year Survey Highlighting an Increasing Epidemiological Threat.
The study identified bla(VIM) and bla(GES) carbapenemase-encoding genes as the most prevalent in Pseudomonas aeruginosa clinical strains, highlighting their increasing epidemiological significance.
Prioritization of Critical Factors for Surveillance of the Dissemination of Antibiotic Resistance in Pseudomonas aeruginosa: A Systematic Review.
The study identifies 25 critical mobile antibiotic resistance genes (ARGs) in Pseudomonas aeruginosa, including genes such as sul1, qacEΔ1, aac(6′)-Ib, bla VIM-1, and others, which are associated with various antibiotic classes and are linked to mobile genetic elements (MGEs).
High prevalence of antibiotic resistance and biofilm formation in Salmonella Gallinarum.
The study identified multiple antibiotic resistance genes in Salmonella Gallinarum isolates, including GES, IMP, VIM, NDM, SHV, KPC, FOX, qnrB, qnrS, and sdiA, which are associated with resistance to various antibiotics. Additionally, all isolates were found to form biofilms, indicating a potential link between biofilm formation and antibiotic resistance.
Decoding the genetic structure of conjugative plasmids in international clones of Klebsiella pneumoniae: A deep dive into blaKPC, blaNDM, blaOXA-48, and blaGES genes.
The study characterizes the genetic structure of plasmids harboring major carbapenemase genes (blaKPC, blaNDM, blaOXA-48, and blaGES) in Klebsiella pneumoniae, identifying the most prevalent allele types and their co-occurrence with other resistance genes.
Decoding the genetic structure of conjugative plasmids in international clones of Klebsiella pneumoniae: A deep dive into blaKPC, blaNDM, blaOXA-48, and blaGES genes.
The study characterizes the genetic structure of plasmids harboring major carbapenemase genes (blaKPC, blaNDM, blaOXA-48, and blaGES) in Klebsiella pneumoniae, identifying the most prevalent allele types and their co-occurrence with other resistance genes.
Plasmid content of carbapenem resistant Acinetobacter baumannii isolates belonging to five International Clones collected from hospitals of Alexandria, Egypt.
The study characterizes various AMR genes in carbapenem-resistant Acinetobacter baumannii isolates, including blaOXA-23, blaPER-7, blaGES-11, blaGES-35, aph(3')-VI, aac(6')-Ib, sul1, sul2, mph(E), msr(E), armA, strA, strB, cmlA5, arr-2, ant(3'')-II, aadA1-pm, tet(B), tet(39), qacEΔ1, and dfrA7.
Plasmid content of carbapenem resistant Acinetobacter baumannii isolates belonging to five International Clones collected from hospitals of Alexandria, Egypt.
The study characterizes various AMR genes in carbapenem-resistant Acinetobacter baumannii isolates, including blaOXA-23, blaPER-7, blaGES-11, blaGES-35, aph(3')-VI, aac(6')-Ib, sul1, sul2, mph(E), msr(E), armA, strA, strB, cmlA5, arr-2, ant(3'')-II, aadA1-pm, tet(B), tet(39), qacEΔ1, and dfrA7.
Evaluation of antimicrobial susceptibility tests for Acinetobacter and Pseudomonas species using disks containing a high dose of meropenem.
The study identified several beta-lactamase genes, including blaIMP-1, blaDIM-1, blaNDM-1, blaVIM-1, blaGES-5, blaOXA-23, blaOXA-51-like, and blaADC, which confer resistance to meropenem in Acinetobacter and Pseudomonas species.
Antimicrobial resistance in aeromonads and new therapies targeting quorum sensing.
The paper discusses the prevalence of antimicrobial resistance in Aeromonas species, highlighting the presence of various beta-lactamase genes such as blaTEM-24, blaIMP-19, blaVIM-4, blaKPC-2, blaNDM-1, blaVIM-2, blaOXA-48, blaIMP-13, blaGES-5, blaTEM-1, blaSHV-12, blaVEB-9, blaMOX, blaFOX, blaACC, and others. It also identifies genes like cphA, vat, mcr-3.41, mcr-7.1, sul, dfr, tetA, rsmA, and adeF associated with resistance to sulfonamides, trimethoprim, tetracycline, polymyxin, and other antibiotics. The study emphasizes the role of horizontal gene transfer and mobile genetic elements in the dissemination of these resistance genes.
Genomic characterization of extended-spectrum beta-lactamase-producing and carbapenem-resistant Escherichia coli from urban wastewater in Australia.
The study identifies multiple AMR genes and mutations in carbapenem-resistant and ESBL-producing E. coli isolates from Australian wastewater, highlighting the presence of resistance mechanisms such as bla NDM-5, bla CMY-42, and mutations in gyrA, parC, and parE.
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase.
NA-1-157 is a potent inhibitor of the GES-5 carbapenemase, reducing MICs of carbapenems against bacteria producing GES-5 by 4-16 fold and showing synergistic effects when combined with meropenem.
Characterization of the diversity of type IV secretion system-encoding plasmids in Acinetobacter.
The study characterizes the diversity of T4SS-encoding plasmids in Acinetobacter, identifying various antibiotic resistance genes such as blaOXA-23, blaOXA-82, blaGES-11, aph(3')-VIa, aadA2, sul1, dfrA7, cmlA1, and qacEΔ1, highlighting their role in multidrug resistance.
Whole-Genome Analysis of Extensively Drug-Resistant Enterobacter hormaechei Isolated from a Patient with Non-Hodgkin's Lymphoma.
The study identifies an extensively drug-resistant Enterobacter hormaechei ST90 clone carrying multiple resistance genes, including bla CTX-M-15, bla GES-2, bla TEM-1A, bla OXA-1, bla NDM-1, and bla ACT-15, along with genes encoding resistance to aminoglycosides, quinolones, sulfonamides, chloramphenicol, fosfomycin, and other antibiotics.
Resistance to ceftazidime-avibactam and other new β-lactams in Pseudomonas aeruginosa clinical isolates: a multi-center surveillance study.
The study identified metallo-beta-lactamases (VIM-2, VIM-1, FIM-1), extended-spectrum beta-lactamases (PER-1, GES-1), and other beta-lactamase genes as the primary mechanisms of resistance to ceftazidime-avibactam in Pseudomonas aeruginosa clinical isolates.
Genomic and phenotypic inconsistencies in Pseudomonas aeruginosa resistome among intensive care patients.
The study identified several AMR genes and mutations in P. aeruginosa isolates from ICU patients, highlighting discrepancies between phenotypic and genotypic resistance profiles. Key findings include the detection of blaGES-5, aac(6')-Ib, aphA15, and mutations in gyrA and parC associated with fluoroquinolone resistance.
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22.
Cefepime-taniborbactam showed potent in vitro activity against Enterobacterales and P. aeruginosa, particularly effective against isolates with carbapenemase genes such as blaIMP, blaNDM, and blaVIM, as well as those with mutations in ftsI, ompK35, and ompK36.
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22.
Cefepime-taniborbactam showed potent in vitro activity against Enterobacterales and P. aeruginosa, particularly effective against isolates with carbapenemase genes such as blaIMP, blaNDM, and blaVIM, as well as those with mutations in ftsI, ompK35, and ompK36.
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22.
Cefepime-taniborbactam showed potent in vitro activity against Enterobacterales and P. aeruginosa, particularly effective against isolates with carbapenemase genes such as blaIMP, blaNDM, and blaVIM, as well as those with mutations in ftsI, ompK35, and ompK36.
Antimicrobial susceptibility to last-resort antibiotics in carbapenemase-producing bacteria from Ukrainian patients.
The study identified multiple carbapenemase genes, including blaNDM, blaOXA-48, blaKPC, blaIMP, blaVIM, and blaGES, which confer resistance to last-resort antibiotics in carbapenemase-producing bacteria from Ukrainian patients.
Gram-Negative Bacilli Blood Stream Infection in Patients with Severe Burns: Microbiological and Clinical Evidence from a 9-Year Cohort.
The study identified several carbapenemase genes, including bla VIM, bla GES, and various OXA-like genes, in Gram-negative bacilli causing bloodstream infections in burn patients, highlighting the prevalence of multidrug-resistant strains.
Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections.
The study identified mutations in the GES-5 carbapenemase (GES-27, GES-29, and GES-60) that lead to resistance against ceftazidime/avibactam, ceftolozane/tazobactam, and cefiderocol in Pseudomonas aeruginosa. These mutations were validated through cloning experiments and MIC testing.
Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections.
The study identified mutations in the GES-5 carbapenemase (GES-27, GES-29, and GES-60) that lead to resistance against ceftazidime/avibactam, ceftolozane/tazobactam, and cefiderocol in Pseudomonas aeruginosa. These mutations were validated through cloning experiments and MIC testing.
Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections.
The study identified mutations in the GES-5 carbapenemase (GES-27, GES-29, and GES-60) that lead to resistance against ceftazidime/avibactam, ceftolozane/tazobactam, and cefiderocol in Pseudomonas aeruginosa. These mutations were validated through cloning experiments and MIC testing.
Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections.
The study identified mutations in the GES-5 carbapenemase (GES-27, GES-29, and GES-60) that lead to resistance against ceftazidime/avibactam, ceftolozane/tazobactam, and cefiderocol in Pseudomonas aeruginosa. These mutations were validated through cloning experiments and MIC testing.
Critical resistance to carbapenem and aminoglycosides in Pseudomonas aeruginosa: spread of bla(NDM)/16S methylase armA harboring isolates with intrinsic resistance mechanisms in Kerman, Iran.
The study identified multiple carbapenemase genes (bla_NDM, bla_IMP, bla_VIM, bla_SIM, bla_GES) and the 16S rRNA methylase gene armA in carbapenem-resistant Pseudomonas aeruginosa isolates from Kerman, Iran. These genes contribute to resistance against carbapenems and aminoglycosides, highlighting the complex resistance mechanisms in these isolates.
A single-center analysis of clonal transmission of carbapenem-resistant Acinetobacter baumannii among intensive care unit patients during the COVID-19 pandemic.
The study identified multiple carbapenem-resistant Acinetobacter baumannii isolates carrying various resistance genes, including bla OXA-40, ISAba-1, int-2, bla OXA-23, bla NDM-1, and several ESBL genes. These findings highlight the complex resistance profiles and clonal transmission of CRAB in ICU settings during the COVID-19 pandemic.
bla(GES)-producing ST654 comprises a quarter of all carbapenem-resistant Pseudomonas aeruginosa in blood isolates from 15 hospitals.
The study identifies bla(GES)-producing ST654 as a significant contributor to carbapenem-resistant Pseudomonas aeruginosa in blood isolates from 15 hospitals, highlighting the prevalence of GES-type carbapenemases and other resistance genes.
bla(GES)-producing ST654 comprises a quarter of all carbapenem-resistant Pseudomonas aeruginosa in blood isolates from 15 hospitals.
The study identifies bla(GES)-producing ST654 as a significant contributor to carbapenem-resistant Pseudomonas aeruginosa in blood isolates from 15 hospitals, highlighting the prevalence of GES-type carbapenemases and other resistance genes.
Prevalence of bla(OXA-48) and other carbapenemase encoding genes among carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Egypt.
The study identified blaVIM, blaOXA-48, blaKPC, blaIMP, blaGES, and blaNDM as prevalent carbapenemase encoding genes among carbapenem-resistant P. aeruginosa isolates in Egypt. blaOXA-48 was frequently associated with the Tn1999 transposon.
Carbapenemase-producing bacteria recovered from Nairobi River, Kenya surface water and from nearby anthropogenic and zoonotic sources.
The study identified multiple carbapenemase-encoding genes, including bla NDM, bla KPC, bla VIM, bla OXA-48-like, bla IMP, and bla GES, in various bacterial species from Nairobi River and surrounding environments.
Multidrug-resistant ESBL-producing Klebsiella pneumoniae complex in Czech hospitals, wastewaters and surface waters.
The study identified multidrug-resistant Klebsiella pneumoniae complex isolates carrying various beta-lactamase genes such as bla CTX-M-15, bla GES-51, bla OXA-48, bla NDM-1, and bla KPC-3, along with other resistance genes like oqxA, oqxB, sul2, aph(6)-Id, dfr14, qnrB1, and aac(6')-Ib-cr.
Clinical evaluation of advanced MALDI-TOF MS for carbapenemase subtyping in Gram-negative isolates.
The study evaluates an advanced MALDI-TOF MS method (A-MALDI) for the accurate identification and subtyping of carbapenemases in Gram-negative clinical isolates, demonstrating 100% accuracy and precision in detecting various carbapenemase subtypes including KPC, NDM, OXA, and GES.
Global genomic epidemiology of bla (GES-5) carbapenemase-associated integrons.
The study characterizes the global genomic epidemiology of blaGES-5, a carbapenemase-associated integron, highlighting its prevalence in Pseudomonas aeruginosa and its association with various gene cassettes.
Activity of ceftolozane/tazobactam and comparators against gram-negative bacilli: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART - Brazil), 2018‒2021.
The study identified several beta-lactamase genes, including bla KPC-2, bla CTX-M variants, and bla NDM-1, which confer resistance to carbapenems and cephalosporins in Gram-negative bacilli in Brazil. These genes were detected in Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolates.
National Multicenter Study on the Prevalence of Carbapenemase-Producing Enterobacteriaceae in the Post-COVID-19 Era in Argentina: The RECAPT-AR Study.
The study identified bla NDM, bla KPC, and bla OXA-163 as the main carbapenemase genes in Enterobacterales isolates from Argentina, with NDM and KPC being the most prevalent.
Next-generation diagnostics of bloodstream infections enabled by rapid whole-genome sequencing of bacterial cells purified from blood cultures.
The study presents a rapid whole-genome sequencing workflow (LC-WGS) for diagnosing bloodstream infections, demonstrating accurate identification of bacterial pathogens and detection of clinically relevant resistance markers within 4.2 hours. The workflow successfully identified various AMR genes, including bla CTX-M-15, bla DHA-1, bla KPC-2, bla KPC-3, bla NDM-1, bla OXA-23, armA, mecA, vanRSHAXYZ, aac(6')-Ie/aph(2'')-Ia, aph(3')-IIIa, aac(6')-I, sul1, and dfrA17.
Rapid prediction of carbapenemases in Pseudomonas aeruginosa by imipenem/relebactam and MALDI-TOF MS.
The study characterizes various carbapenemase genes such as blaIMP-13, blaIMP-94, blaNDM-1, blaNDM-5, blaNDM-7, blaNDM-23, blaVIM-1, blaVIM-2, blaVIM-20, blaKPC-2, blaKPC-3, blaGES-1, blaGES-5, blaGES-7, blaGES-20, blaPER-1, blaVEB-1, blaCTX-M-15, blaCTX-M-9, blaSHV-12, blaFOX-4, blaCMY-2, blaDHA-1, blaOXA-2, blaOXA-10, blaOXA-14, blaOXA-15, and blaOXA-48 in Pseudomonas aeruginosa using MALDI-TOF MS hydrolysis assays.
Rapid prediction of carbapenemases in Pseudomonas aeruginosa by imipenem/relebactam and MALDI-TOF MS.
The study characterizes various carbapenemase genes such as blaIMP-13, blaIMP-94, blaNDM-1, blaNDM-5, blaNDM-7, blaNDM-23, blaVIM-1, blaVIM-2, blaVIM-20, blaKPC-2, blaKPC-3, blaGES-1, blaGES-5, blaGES-7, blaGES-20, blaPER-1, blaVEB-1, blaCTX-M-15, blaCTX-M-9, blaSHV-12, blaFOX-4, blaCMY-2, blaDHA-1, blaOXA-2, blaOXA-10, blaOXA-14, blaOXA-15, and blaOXA-48 in Pseudomonas aeruginosa using MALDI-TOF MS hydrolysis assays.
Rapid prediction of carbapenemases in Pseudomonas aeruginosa by imipenem/relebactam and MALDI-TOF MS.
The study characterizes various carbapenemase genes such as blaIMP-13, blaIMP-94, blaNDM-1, blaNDM-5, blaNDM-7, blaNDM-23, blaVIM-1, blaVIM-2, blaVIM-20, blaKPC-2, blaKPC-3, blaGES-1, blaGES-5, blaGES-7, blaGES-20, blaPER-1, blaVEB-1, blaCTX-M-15, blaCTX-M-9, blaSHV-12, blaFOX-4, blaCMY-2, blaDHA-1, blaOXA-2, blaOXA-10, blaOXA-14, blaOXA-15, and blaOXA-48 in Pseudomonas aeruginosa using MALDI-TOF MS hydrolysis assays.
Rapid prediction of carbapenemases in Pseudomonas aeruginosa by imipenem/relebactam and MALDI-TOF MS.
The study characterizes various carbapenemase genes such as blaIMP-13, blaIMP-94, blaNDM-1, blaNDM-5, blaNDM-7, blaNDM-23, blaVIM-1, blaVIM-2, blaVIM-20, blaKPC-2, blaKPC-3, blaGES-1, blaGES-5, blaGES-7, blaGES-20, blaPER-1, blaVEB-1, blaCTX-M-15, blaCTX-M-9, blaSHV-12, blaFOX-4, blaCMY-2, blaDHA-1, blaOXA-2, blaOXA-10, blaOXA-14, blaOXA-15, and blaOXA-48 in Pseudomonas aeruginosa using MALDI-TOF MS hydrolysis assays.
Diagnostic algorithm for the detection of carbapenemases and extended-spectrum β-lactamases in carbapenem-resistant Pseudomonas aeruginosa.
The study identifies several carbapenemase and extended-spectrum beta-lactamase genes, including bla(VIM-2), bla(VIM-4), bla(IMP-1), bla(NDM-1), bla(GES-5), and bla(KPC-2), which confer resistance to carbapenems and other beta-lactam antibiotics in carbapenem-resistant Pseudomonas aeruginosa.
Diagnostic algorithm for the detection of carbapenemases and extended-spectrum β-lactamases in carbapenem-resistant Pseudomonas aeruginosa.
The study identifies several carbapenemase and extended-spectrum beta-lactamase genes, including bla(VIM-2), bla(VIM-4), bla(IMP-1), bla(NDM-1), bla(GES-5), and bla(KPC-2), which confer resistance to carbapenems and other beta-lactam antibiotics in carbapenem-resistant Pseudomonas aeruginosa.
The ongoing antibiotic resistance and carbapenemase encoding genotypes surveillance. The first quarter report of the INVIFAR network for 2024.
The study identifies bla NDM, bla KPC, bla OXA24, and bla GES as carbapenemase-encoding genes in various bacterial species, highlighting their role in carbapenem resistance.
Prevalence and molecular characterisation of multi-drug resistant ST11 hypervirulent Klebsiella pneumoniae in a teaching hospital.
The study identifies several AMR genes in CRKP strains, including bla KPC-2, bla NDM-1, bla VIM, bla SHV-12, bla TEM-1b, aac(6')-Ib-cr, qnrS, qnrB, rmtB, ant(3'')-I, armA, sul1, sul2, iucA, iutA, iroN, ybtS, mrkD, fimH, and p rmpA. These genes confer resistance to carbapenems, quinolones, aminoglycosides, and sulfonamides. Additionally, the study highlights the transferability of these genes through conjugation.
Characterization of the Diversity in Host Range of an Extensively Drug-Resistant (XDR) Type IV Secretion System-Encoding Plasmid in Acinetobacter.
The study characterizes the XDR plasmid p1AB5075, which harbors multiple antibiotic resistance genes, including blaGES-11, aac(6')-Ib10, ant(2")-Ia, aadA2, aph(3")-Ib, aph(6)-Id, cmlA1, dfrA7, sul1, and qacEΔ1, conferring resistance to various antibiotics such as beta-lactams, aminoglycosides, chloramphenicol, trimethoprim, and sulfonamides. The plasmid was successfully transferred to genetically diverse Acinetobacter strains, highlighting its potential for spreading resistance.
Massive culture-based approach for the screening of AmpC, ESBL, and carbapenemase producers from rectal swabs.
The study presents a massive culture-based approach for the screening of AmpC, ESBL, and carbapenemase producers from rectal swabs, demonstrating improved specificity for detecting ESBL producers compared to conventional methods. It identifies various beta-lactamase genes, including bla CTX-M-1/2-like, bla CTX-M-8-like, bla CTX-M-9-like, bla SHV-like, bla TEM-like, bla GES-like, bla MOX, bla CIT, bla DHA, bla ACC, bla EBC, bla FOX, bla CMY-2, and bla NDM.
Impact of Dietary Inputs on Carbapenem Resistance Gene Dynamics and Microbial Safety During Bioconversion of Agri-Food Waste and Anaerobic Digestate by Hermetia illucens Larvae.
The study identifies the presence of carbapenem resistance genes (bla VIM, bla OXA-48, bla GES, and bla KPC) in Hermetia illucens larvae and frass, primarily associated with legume-based diets. These genes were not detected in young larvae or in diets containing onion or digestate.
Investigation of carbapenemase-encoding genes in Burkholderia cepacia and Aeromonas sobria isolates from nosocomial infections in Iraqi patients.
The study identified bla KPC and bla GES carbapenemase genes in Burkholderia cepacia and Aeromonas sobria isolates, which confer resistance to meropenem and imipenem.
Mechanistic basis for inhibition of the extended-spectrum beta-lactamase GES-1 by enmetazobactam and tazobactam.
The study identifies GES-1 as a beta-lactamase that is inhibited by enmetazobactam and tazobactam, with enmetazobactam showing greater potency against GES-1 compared to tazobactam.
Towards the integration of antibiotic resistance gene mobility into environmental surveillance and risk assessment.
The study highlights the importance of incorporating antibiotic resistance gene (ARG) mobility into environmental surveillance and risk assessment. It identifies specific ARGs such as bla OXA, bla KPC-2, bla TEM-1, bla GES-2, bla GES-5, sul 1, and sul 2 as highly mobile and potentially risky in various environmental settings.
Towards the integration of antibiotic resistance gene mobility into environmental surveillance and risk assessment.
The study highlights the importance of incorporating antibiotic resistance gene (ARG) mobility into environmental surveillance and risk assessment. It identifies specific ARGs such as bla OXA, bla KPC-2, bla TEM-1, bla GES-2, bla GES-5, sul 1, and sul 2 as highly mobile and potentially risky in various environmental settings.
In vitro activity of cefiderocol against nosocomial Acinetobacter baumannii.
The study assessed the in vitro activity of cefiderocol against multidrug-resistant Acinetobacter baumannii isolates and found that cefiderocol exhibited high efficacy, with very low resistance rates. However, the presence of various beta-lactamase genes, including bla OXA-23G, bla OXA-24G, bla OXA-48G, bla OXA-58G, bla VEB, bla PER, bla GES, bla KPC, bla NDM, bla VIM, bla IMP, and bla IMI, was associated with resistance to other antibiotics.
Whole-genome sequencing reveals resistance mechanisms and molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa bloodstream infections.
The study identified oprD mutations and efflux pumps hyperexpression as dominant drivers of carbapenem resistance in CRPA strains, with carbapenemase emerging as a clinically significant pathway.
AgNPs treatment reduces time recovery and increases bacterial sensitivity to antibiotics in cow´s purulent catarrhal endometritis. A translational study.
The study found that Argovit-C treatment reduced the prevalence of blaGES and blaDHA resistance genes in E. coli isolates from cows with purulent catarrhal endometritis, indicating a potential to limit the spread of antibiotic resistance.
Multidrug-resistant Pseudomonas aeruginosa: Pathogenesis, resistance mechanisms, and novel therapeutic strategies.
The paper discusses the multidrug resistance mechanisms of Pseudomonas aeruginosa, including beta-lactamases, aminoglycoside modifying enzymes, efflux pumps, and mutations in porin genes. It highlights the role of these mechanisms in antibiotic resistance and the challenges they pose in treating infections.
First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology.
The study identified multiple carbapenemases, extended-spectrum beta-lactamases, and 16S rRNA methyltransferases in multidrug-resistant Pseudomonas aeruginosa isolates from Bolivia, highlighting the prevalence of high-risk clones and resistance mechanisms.
Characterisation of Plasmid-Associated Antimicrobial Resistance Genes in Coastal Marine Enterobacterales from the Central Adriatic Sea: De Novo Assembly and Bioinformatic Profiling.
The study identified nine clinically relevant antimicrobial resistance genes (ARGs) in plasmid-like assemblies from marine Enterobacterales, including blaKPC, blaTEM, aacA4, folP, and tetA, highlighting the potential for horizontal gene transfer in coastal environments.
Diversity in Carbapenemases in Enterobacterales in Southeastern Austria Before and During the COVID-19 Pandemic.
The study identified various carbapenemase genes, including blaVIM-1, blaNDM-1, blaOXA-48, blaOXA-181, blaOXA-244, blaKPC-2, blaKPC-3, and blaGES, in carbapenem-resistant Enterobacterales isolates from Southeastern Austria. The prevalence of CRE decreased during the COVID-19 pandemic, and dual-carbapenemase-producing isolates were observed for the first time.
Global emergence of Acinetobacter baumannii International Clone 12 predominantly found in the Middle East.
The study identifies multiple acquired antimicrobial resistance genes in Acinetobacter baumannii International Clone 12, including bla OXA-23, bla GES-11, bla GES-12, bla GES-22, bla GES-35, bla CARB-16, bla CARB-49, aphA6a, aadB, strA, strB, cmlA1, aadA2b, sul1, drfA7, dfrA1, qacE, tet(B), tet(X3), msr(E), mph(E), bla TEM-1B, and aacC3. These genes contribute to resistance against various antibiotics, highlighting the complexity of resistance mechanisms in this clone.
Global emergence of Acinetobacter baumannii International Clone 12 predominantly found in the Middle East.
The study identifies multiple acquired antimicrobial resistance genes in Acinetobacter baumannii International Clone 12, including bla OXA-23, bla GES-11, bla GES-12, bla GES-22, bla GES-35, bla CARB-16, bla CARB-49, aphA6a, aadB, strA, strB, cmlA1, aadA2b, sul1, drfA7, dfrA1, qacE, tet(B), tet(X3), msr(E), mph(E), bla TEM-1B, and aacC3. These genes contribute to resistance against various antibiotics, highlighting the complexity of resistance mechanisms in this clone.
Global emergence of Acinetobacter baumannii International Clone 12 predominantly found in the Middle East.
The study identifies multiple acquired antimicrobial resistance genes in Acinetobacter baumannii International Clone 12, including bla OXA-23, bla GES-11, bla GES-12, bla GES-22, bla GES-35, bla CARB-16, bla CARB-49, aphA6a, aadB, strA, strB, cmlA1, aadA2b, sul1, drfA7, dfrA1, qacE, tet(B), tet(X3), msr(E), mph(E), bla TEM-1B, and aacC3. These genes contribute to resistance against various antibiotics, highlighting the complexity of resistance mechanisms in this clone.
Global emergence of Acinetobacter baumannii International Clone 12 predominantly found in the Middle East.
The study identifies multiple acquired antimicrobial resistance genes in Acinetobacter baumannii International Clone 12, including bla OXA-23, bla GES-11, bla GES-12, bla GES-22, bla GES-35, bla CARB-16, bla CARB-49, aphA6a, aadB, strA, strB, cmlA1, aadA2b, sul1, drfA7, dfrA1, qacE, tet(B), tet(X3), msr(E), mph(E), bla TEM-1B, and aacC3. These genes contribute to resistance against various antibiotics, highlighting the complexity of resistance mechanisms in this clone.
Genetic Analysis of Virulence and β-Lactamase Determinants Related to β-Lactamase Inhibitors in Pseudomonas aeruginosa Strains from Nosocomial Infections.
The study identifies several β-lactamase genes (bla OXA-2, bla OXA-4, and bla GES) and virulence genes (aprA, pIcH, pIcN, lasA, lasB, rhLA, lasI, and rhII) associated with resistance to β-lactamase inhibitor antibiotics in Pseudomonas aeruginosa strains from nosocomial infections.
No comments yet. Be the first to comment!